{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "7d2775d9",
   "metadata": {},
   "outputs": [
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m                         Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[1], line 2\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[38;5;28;01mimport\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01mos\u001b[39;00m\n\u001b[0;32m----> 2\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01mdatasets\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m load_dataset\n\u001b[1;32m      4\u001b[0m ds \u001b[38;5;241m=\u001b[39m load_dataset(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mccdv/pubmed-summarization\u001b[39m\u001b[38;5;124m\"\u001b[39m, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mdocument\u001b[39m\u001b[38;5;124m\"\u001b[39m, cache_dir\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m./my_local_cache\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n",
      "File \u001b[0;32m/ocean/projects/cis230089p/slin23/miniconda3/envs/gptoss20b/lib/python3.10/site-packages/datasets/__init__.py:17\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[38;5;66;03m# Copyright 2020 The HuggingFace Datasets Authors and the TensorFlow Datasets Authors.\u001b[39;00m\n\u001b[1;32m      2\u001b[0m \u001b[38;5;66;03m#\u001b[39;00m\n\u001b[1;32m      3\u001b[0m \u001b[38;5;66;03m# Licensed under the Apache License, Version 2.0 (the \"License\");\u001b[39;00m\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m     12\u001b[0m \u001b[38;5;66;03m# See the License for the specific language governing permissions and\u001b[39;00m\n\u001b[1;32m     13\u001b[0m \u001b[38;5;66;03m# limitations under the License.\u001b[39;00m\n\u001b[1;32m     15\u001b[0m __version__ \u001b[38;5;241m=\u001b[39m \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m3.6.0\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[0;32m---> 17\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01marrow_dataset\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m Dataset\n\u001b[1;32m     18\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01marrow_reader\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m ReadInstruction\n\u001b[1;32m     19\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mbuilder\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m ArrowBasedBuilder, BuilderConfig, DatasetBuilder, GeneratorBasedBuilder\n",
      "File \u001b[0;32m/ocean/projects/cis230089p/slin23/miniconda3/envs/gptoss20b/lib/python3.10/site-packages/datasets/arrow_dataset.py:54\u001b[0m\n\u001b[1;32m     43\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01mrandom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m sample\n\u001b[1;32m     44\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01mtyping\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m (\n\u001b[1;32m     45\u001b[0m     TYPE_CHECKING,\n\u001b[1;32m     46\u001b[0m     Any,\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m     51\u001b[0m     overload,\n\u001b[1;32m     52\u001b[0m )\n\u001b[0;32m---> 54\u001b[0m \u001b[38;5;28;01mimport\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01mfsspec\u001b[39;00m\n\u001b[1;32m     55\u001b[0m \u001b[38;5;28;01mimport\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01mnumpy\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mas\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01mnp\u001b[39;00m\n\u001b[1;32m     56\u001b[0m \u001b[38;5;28;01mimport\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01mpandas\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mas\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01mpd\u001b[39;00m\n",
      "File \u001b[0;32m/ocean/projects/cis230089p/slin23/miniconda3/envs/gptoss20b/lib/python3.10/site-packages/fsspec/__init__.py:6\u001b[0m\n\u001b[1;32m      4\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01m_version\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m __version__  \u001b[38;5;66;03m# noqa: F401\u001b[39;00m\n\u001b[1;32m      5\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mcallbacks\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m Callback\n\u001b[0;32m----> 6\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mcompression\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m available_compressions\n\u001b[1;32m      7\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mcore\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m get_fs_token_paths, \u001b[38;5;28mopen\u001b[39m, open_files, open_local, url_to_fs\n\u001b[1;32m      8\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mexceptions\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m FSTimeoutError\n",
      "File \u001b[0;32m/ocean/projects/cis230089p/slin23/miniconda3/envs/gptoss20b/lib/python3.10/site-packages/fsspec/compression.py:6\u001b[0m\n\u001b[1;32m      3\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01mzipfile\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m ZipFile\n\u001b[1;32m      5\u001b[0m \u001b[38;5;28;01mimport\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01mfsspec\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mutils\u001b[39;00m\n\u001b[0;32m----> 6\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01mfsspec\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mspec\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m AbstractBufferedFile\n\u001b[1;32m      9\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21mnoop_file\u001b[39m(file, mode, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs):\n\u001b[1;32m     10\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m file\n",
      "File \u001b[0;32m/ocean/projects/cis230089p/slin23/miniconda3/envs/gptoss20b/lib/python3.10/site-packages/fsspec/spec.py:17\u001b[0m\n\u001b[1;32m     15\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mcallbacks\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m DEFAULT_CALLBACK\n\u001b[1;32m     16\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mconfig\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m apply_config, conf\n\u001b[0;32m---> 17\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mdircache\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m DirCache\n\u001b[1;32m     18\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mtransaction\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m Transaction\n\u001b[1;32m     19\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mutils\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mimport\u001b[39;00m (\n\u001b[1;32m     20\u001b[0m     _unstrip_protocol,\n\u001b[1;32m     21\u001b[0m     glob_translate,\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m     26\u001b[0m     tokenize,\n\u001b[1;32m     27\u001b[0m )\n",
      "File \u001b[0;32m<frozen importlib._bootstrap>:1027\u001b[0m, in \u001b[0;36m_find_and_load\u001b[0;34m(name, import_)\u001b[0m\n",
      "File \u001b[0;32m<frozen importlib._bootstrap>:1006\u001b[0m, in \u001b[0;36m_find_and_load_unlocked\u001b[0;34m(name, import_)\u001b[0m\n",
      "File \u001b[0;32m<frozen importlib._bootstrap>:688\u001b[0m, in \u001b[0;36m_load_unlocked\u001b[0;34m(spec)\u001b[0m\n",
      "File \u001b[0;32m<frozen importlib._bootstrap_external>:879\u001b[0m, in \u001b[0;36mexec_module\u001b[0;34m(self, module)\u001b[0m\n",
      "File \u001b[0;32m<frozen importlib._bootstrap_external>:975\u001b[0m, in \u001b[0;36mget_code\u001b[0;34m(self, fullname)\u001b[0m\n",
      "File \u001b[0;32m<frozen importlib._bootstrap_external>:1074\u001b[0m, in \u001b[0;36mget_data\u001b[0;34m(self, path)\u001b[0m\n",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m: "
     ]
    }
   ],
   "source": [
    "import os\n",
    "from datasets import load_dataset\n",
    "\n",
    "ds = load_dataset(\"ccdv/pubmed-summarization\", \"document\", cache_dir=\"./my_local_cache\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "3b743c8a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article</th>\n",
       "      <th>abstract</th>\n",
       "      <th>background</th>\n",
       "      <th>objective</th>\n",
       "      <th>methods</th>\n",
       "      <th>results</th>\n",
       "      <th>conclusions</th>\n",
       "      <th>none</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>anxiety affects quality of life in those livin...</td>\n",
       "      <td>research on the implications of anxiety in par...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>anxiety affects quality of life in those livin...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>small non - coding rnas are transcribed into m...</td>\n",
       "      <td>small non - coding rnas include sirna , mirna ...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>small non - coding rnas are transcribed into m...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ohss is a serious complication of ovulation in...</td>\n",
       "      <td>objective : to evaluate the efficacy and safet...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>ohss is a serious complication of ovulation in...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>congenital adrenal hyperplasia ( cah ) refers ...</td>\n",
       "      <td>congenital adrenal hyperplasia is a group of a...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>congenital adrenal hyperplasia ( cah ) refers ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>type 1 diabetes ( t1d ) results from the destr...</td>\n",
       "      <td>objective(s):pentoxifylline is an immunomodula...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>type 1 diabetes ( t1d ) results from the destr...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6653</th>\n",
       "      <td>neurocysticercosis is the most common parasiti...</td>\n",
       "      <td>cysticercosis is an infection with larval cyst...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>neurocysticercosis is the most common parasiti...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6654</th>\n",
       "      <td>most chd prevalence data are based on populati...</td>\n",
       "      <td>background : congenital heart disease ( chd ) ...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>most chd prevalence data are based on populati...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6655</th>\n",
       "      <td>renal transplantation rates are low among pati...</td>\n",
       "      <td>we describe a successful living donor liver tr...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>renal transplantation rates are low among pati...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6656</th>\n",
       "      <td>acute kidney injury ( aki ) , defined as an ab...</td>\n",
       "      <td>objective : the aim was to investigate the eff...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>acute kidney injury ( aki ) , defined as an ab...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6657</th>\n",
       "      <td>human brain plasticity or neuroplasticity refe...</td>\n",
       "      <td>accumulating evidence has indicated that amput...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>human brain plasticity or neuroplasticity refe...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6658 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                article  \\\n",
       "0     anxiety affects quality of life in those livin...   \n",
       "1     small non - coding rnas are transcribed into m...   \n",
       "2     ohss is a serious complication of ovulation in...   \n",
       "3     congenital adrenal hyperplasia ( cah ) refers ...   \n",
       "4     type 1 diabetes ( t1d ) results from the destr...   \n",
       "...                                                 ...   \n",
       "6653  neurocysticercosis is the most common parasiti...   \n",
       "6654  most chd prevalence data are based on populati...   \n",
       "6655  renal transplantation rates are low among pati...   \n",
       "6656  acute kidney injury ( aki ) , defined as an ab...   \n",
       "6657  human brain plasticity or neuroplasticity refe...   \n",
       "\n",
       "                                               abstract background objective  \\\n",
       "0     research on the implications of anxiety in par...                        \n",
       "1     small non - coding rnas include sirna , mirna ...                        \n",
       "2     objective : to evaluate the efficacy and safet...                        \n",
       "3     congenital adrenal hyperplasia is a group of a...                        \n",
       "4     objective(s):pentoxifylline is an immunomodula...                        \n",
       "...                                                 ...        ...       ...   \n",
       "6653  cysticercosis is an infection with larval cyst...                        \n",
       "6654  background : congenital heart disease ( chd ) ...                        \n",
       "6655  we describe a successful living donor liver tr...                        \n",
       "6656  objective : the aim was to investigate the eff...                        \n",
       "6657  accumulating evidence has indicated that amput...                        \n",
       "\n",
       "                                                methods  \\\n",
       "0                                                         \n",
       "1     small non - coding rnas are transcribed into m...   \n",
       "2                                                         \n",
       "3                                                         \n",
       "4     type 1 diabetes ( t1d ) results from the destr...   \n",
       "...                                                 ...   \n",
       "6653                                                      \n",
       "6654  most chd prevalence data are based on populati...   \n",
       "6655  renal transplantation rates are low among pati...   \n",
       "6656                                                      \n",
       "6657  human brain plasticity or neuroplasticity refe...   \n",
       "\n",
       "                                                results conclusions  \\\n",
       "0     anxiety affects quality of life in those livin...               \n",
       "1                                                                     \n",
       "2     ohss is a serious complication of ovulation in...               \n",
       "3                                                                     \n",
       "4                                                                     \n",
       "...                                                 ...         ...   \n",
       "6653  neurocysticercosis is the most common parasiti...               \n",
       "6654                                                                  \n",
       "6655                                                                  \n",
       "6656                                                                  \n",
       "6657                                                                  \n",
       "\n",
       "                                                   none  \n",
       "0                                                        \n",
       "1                                                        \n",
       "2                                                        \n",
       "3     congenital adrenal hyperplasia ( cah ) refers ...  \n",
       "4                                                        \n",
       "...                                                 ...  \n",
       "6653                                                     \n",
       "6654                                                     \n",
       "6655                                                     \n",
       "6656  acute kidney injury ( aki ) , defined as an ab...  \n",
       "6657                                                     \n",
       "\n",
       "[6658 rows x 8 columns]"
      ]
     },
     "execution_count": 1,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "\n",
    "\n",
    "df = pd.read_json(\"dataset/pubmed-summarization-stream.jsonl\", lines=True)\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6bc87d4e",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "4cef78d5",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "\n",
    "\n",
    "df = pd.read_json(\"dataset/classified_articles_stream.jsonl\", lines=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "2ae9bb88",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>article_id</th>\n",
       "      <th>pmid</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>article</th>\n",
       "      <th>missing_fields</th>\n",
       "      <th>background</th>\n",
       "      <th>objective</th>\n",
       "      <th>methods</th>\n",
       "      <th>results</th>\n",
       "      <th>conclusions</th>\n",
       "      <th>none</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>PMC696377</td>\n",
       "      <td>31842374</td>\n",
       "      <td>Plasmodesmata Conductivity Regulation: A Mecha...</td>\n",
       "      <td>&lt;S&gt; plant cells form a multicellular symplast ...</td>\n",
       "      <td>due to their immobile lifestyle, plants are ex...</td>\n",
       "      <td>[]</td>\n",
       "      <td>calreticulin, a ca-sequestering protein chaper...</td>\n",
       "      <td></td>\n",
       "      <td>the cytoskeletal proteins actin and myosin hav...</td>\n",
       "      <td>due to their immobile lifestyle, plants are ex...</td>\n",
       "      <td>the structure of a typical simple pd (figure 1...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>PMC958938</td>\n",
       "      <td>36324544</td>\n",
       "      <td>Abderrazak Hajjioui: shining a light on rehabi...</td>\n",
       "      <td>&lt;S&gt; abderrazak hajjioui talks to tatum anderso...</td>\n",
       "      <td>i noticed that moroccan practitioners tended t...</td>\n",
       "      <td>[]</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>i noticed that moroccan practitioners tended t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>PMC561342</td>\n",
       "      <td>28970690</td>\n",
       "      <td>Successful surgical procedure in a patient of ...</td>\n",
       "      <td>&lt;S&gt; this case marks the beginning of issuing c...</td>\n",
       "      <td>cci may be done at 10 min, 1 h, or 24 h after ...</td>\n",
       "      <td>[]</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>cci may be done at 10 min, 1 h, or 24 h after ...</td>\n",
       "      <td></td>\n",
       "      <td>when hla antibodies are present, patients may ...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>PMC642025</td>\n",
       "      <td>30875402</td>\n",
       "      <td>Assessment of early goal-directed therapy guid...</td>\n",
       "      <td>&lt;S&gt; background\\nassessing adherence to early g...</td>\n",
       "      <td>assessing adherence to early goal-directed the...</td>\n",
       "      <td>[]</td>\n",
       "      <td>assessing adherence to early goal-directed the...</td>\n",
       "      <td></td>\n",
       "      <td>this study started with review of existing evi...</td>\n",
       "      <td>severe sepsis and septic shock are associated ...</td>\n",
       "      <td>adherence determination based on selected clin...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>PMC579575</td>\n",
       "      <td>29172801</td>\n",
       "      <td>The new European guideline on cardiovascular d...</td>\n",
       "      <td>&lt;S&gt; abstract\\nthe new guideline on cardiovascu...</td>\n",
       "      <td>in the new guideline , the accessible and simp...</td>\n",
       "      <td>[]</td>\n",
       "      <td>the new guideline acknowledges that especially...</td>\n",
       "      <td></td>\n",
       "      <td>to improve the translation of the recommendati...</td>\n",
       "      <td></td>\n",
       "      <td>in the new guideline , the accessible and simp...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4626</th>\n",
       "      <td>PMC883360</td>\n",
       "      <td>35158828</td>\n",
       "      <td>Alternative Splicing, Epigenetic Modifications...</td>\n",
       "      <td>&lt;S&gt; simple summary\\nepigenetics studies the al...</td>\n",
       "      <td>epigenetics studies the alteration of gene exp...</td>\n",
       "      <td>[]</td>\n",
       "      <td>epigenetics studies the alteration of gene exp...</td>\n",
       "      <td>knowledge of rna splicing in cancer may lead t...</td>\n",
       "      <td>in spite of the advances in precision medicine...</td>\n",
       "      <td>the most classical epigenetic modifications, d...</td>\n",
       "      <td>since the launching of the encode project in 2...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4627</th>\n",
       "      <td>PMC424766</td>\n",
       "      <td>25403234</td>\n",
       "      <td>Let it grow—the open market solution to mariju...</td>\n",
       "      <td>&lt;S&gt; this commentary evaluates regulatory frame...</td>\n",
       "      <td>this article presents the case for legalizing ...</td>\n",
       "      <td>[]</td>\n",
       "      <td>marijuana’s legalization raises numerous criti...</td>\n",
       "      <td></td>\n",
       "      <td>this article presents the case for legalizing ...</td>\n",
       "      <td></td>\n",
       "      <td>marijuana’s prospective legalization should be...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4628</th>\n",
       "      <td>PMC766392</td>\n",
       "      <td>33167486</td>\n",
       "      <td>Gated Dehazing Network via Least Square Advers...</td>\n",
       "      <td>&lt;S&gt; in a hazy environment, visibility is reduc...</td>\n",
       "      <td>especially, haze reduces the visibility of the...</td>\n",
       "      <td>[]</td>\n",
       "      <td>a haze image ix acquired by a digital image se...</td>\n",
       "      <td></td>\n",
       "      <td>especially, haze reduces the visibility of the...</td>\n",
       "      <td>to train the proposed model, adam optimizer wa...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4629</th>\n",
       "      <td>PMC436037</td>\n",
       "      <td>21147631</td>\n",
       "      <td>Lung mass in a 28-year-old male: A case report...</td>\n",
       "      <td>&lt;S&gt; a twenty eight-year-old male presented wit...</td>\n",
       "      <td>it has distinct pathologic features and occurs...</td>\n",
       "      <td>[]</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>hepatocellular carcinoma is a highly malignant...</td>\n",
       "      <td>it has distinct pathologic features and occurs...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4630</th>\n",
       "      <td>PMC42858</td>\n",
       "      <td>15157276</td>\n",
       "      <td></td>\n",
       "      <td>&lt;S&gt; the important role of apoav gene t-1131&gt;c ...</td>\n",
       "      <td>on the association between the t-1131&gt;c apoav ...</td>\n",
       "      <td>['title']</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>on the association between the t-1131&gt;c apoav ...</td>\n",
       "      <td></td>\n",
       "      <td>we conclude that the t-1131&gt;c variant in the a...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>4631 rows × 12 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     article_id      pmid                                              title  \\\n",
       "0     PMC696377  31842374  Plasmodesmata Conductivity Regulation: A Mecha...   \n",
       "1     PMC958938  36324544  Abderrazak Hajjioui: shining a light on rehabi...   \n",
       "2     PMC561342  28970690  Successful surgical procedure in a patient of ...   \n",
       "3     PMC642025  30875402  Assessment of early goal-directed therapy guid...   \n",
       "4     PMC579575  29172801  The new European guideline on cardiovascular d...   \n",
       "...         ...       ...                                                ...   \n",
       "4626  PMC883360  35158828  Alternative Splicing, Epigenetic Modifications...   \n",
       "4627  PMC424766  25403234  Let it grow—the open market solution to mariju...   \n",
       "4628  PMC766392  33167486  Gated Dehazing Network via Least Square Advers...   \n",
       "4629  PMC436037  21147631  Lung mass in a 28-year-old male: A case report...   \n",
       "4630   PMC42858  15157276                                                      \n",
       "\n",
       "                                               abstract  \\\n",
       "0     <S> plant cells form a multicellular symplast ...   \n",
       "1     <S> abderrazak hajjioui talks to tatum anderso...   \n",
       "2     <S> this case marks the beginning of issuing c...   \n",
       "3     <S> background\\nassessing adherence to early g...   \n",
       "4     <S> abstract\\nthe new guideline on cardiovascu...   \n",
       "...                                                 ...   \n",
       "4626  <S> simple summary\\nepigenetics studies the al...   \n",
       "4627  <S> this commentary evaluates regulatory frame...   \n",
       "4628  <S> in a hazy environment, visibility is reduc...   \n",
       "4629  <S> a twenty eight-year-old male presented wit...   \n",
       "4630  <S> the important role of apoav gene t-1131>c ...   \n",
       "\n",
       "                                                article missing_fields  \\\n",
       "0     due to their immobile lifestyle, plants are ex...             []   \n",
       "1     i noticed that moroccan practitioners tended t...             []   \n",
       "2     cci may be done at 10 min, 1 h, or 24 h after ...             []   \n",
       "3     assessing adherence to early goal-directed the...             []   \n",
       "4     in the new guideline , the accessible and simp...             []   \n",
       "...                                                 ...            ...   \n",
       "4626  epigenetics studies the alteration of gene exp...             []   \n",
       "4627  this article presents the case for legalizing ...             []   \n",
       "4628  especially, haze reduces the visibility of the...             []   \n",
       "4629  it has distinct pathologic features and occurs...             []   \n",
       "4630  on the association between the t-1131>c apoav ...      ['title']   \n",
       "\n",
       "                                             background  \\\n",
       "0     calreticulin, a ca-sequestering protein chaper...   \n",
       "1                                                         \n",
       "2                                                         \n",
       "3     assessing adherence to early goal-directed the...   \n",
       "4     the new guideline acknowledges that especially...   \n",
       "...                                                 ...   \n",
       "4626  epigenetics studies the alteration of gene exp...   \n",
       "4627  marijuana’s legalization raises numerous criti...   \n",
       "4628  a haze image ix acquired by a digital image se...   \n",
       "4629                                                      \n",
       "4630                                                      \n",
       "\n",
       "                                              objective  \\\n",
       "0                                                         \n",
       "1                                                         \n",
       "2                                                         \n",
       "3                                                         \n",
       "4                                                         \n",
       "...                                                 ...   \n",
       "4626  knowledge of rna splicing in cancer may lead t...   \n",
       "4627                                                      \n",
       "4628                                                      \n",
       "4629                                                      \n",
       "4630                                                      \n",
       "\n",
       "                                                methods  \\\n",
       "0     the cytoskeletal proteins actin and myosin hav...   \n",
       "1                                                         \n",
       "2     cci may be done at 10 min, 1 h, or 24 h after ...   \n",
       "3     this study started with review of existing evi...   \n",
       "4     to improve the translation of the recommendati...   \n",
       "...                                                 ...   \n",
       "4626  in spite of the advances in precision medicine...   \n",
       "4627  this article presents the case for legalizing ...   \n",
       "4628  especially, haze reduces the visibility of the...   \n",
       "4629                                                      \n",
       "4630  on the association between the t-1131>c apoav ...   \n",
       "\n",
       "                                                results  \\\n",
       "0     due to their immobile lifestyle, plants are ex...   \n",
       "1                                                         \n",
       "2                                                         \n",
       "3     severe sepsis and septic shock are associated ...   \n",
       "4                                                         \n",
       "...                                                 ...   \n",
       "4626  the most classical epigenetic modifications, d...   \n",
       "4627                                                      \n",
       "4628  to train the proposed model, adam optimizer wa...   \n",
       "4629  hepatocellular carcinoma is a highly malignant...   \n",
       "4630                                                      \n",
       "\n",
       "                                            conclusions  \\\n",
       "0     the structure of a typical simple pd (figure 1...   \n",
       "1                                                         \n",
       "2     when hla antibodies are present, patients may ...   \n",
       "3     adherence determination based on selected clin...   \n",
       "4     in the new guideline , the accessible and simp...   \n",
       "...                                                 ...   \n",
       "4626  since the launching of the encode project in 2...   \n",
       "4627  marijuana’s prospective legalization should be...   \n",
       "4628                                                      \n",
       "4629  it has distinct pathologic features and occurs...   \n",
       "4630  we conclude that the t-1131>c variant in the a...   \n",
       "\n",
       "                                                   none  \n",
       "0                                                        \n",
       "1     i noticed that moroccan practitioners tended t...  \n",
       "2                                                        \n",
       "3                                                        \n",
       "4                                                        \n",
       "...                                                 ...  \n",
       "4626                                                     \n",
       "4627                                                     \n",
       "4628                                                     \n",
       "4629                                                     \n",
       "4630                                                     \n",
       "\n",
       "[4631 rows x 12 columns]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "071739a5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "background:  diabetes mellitus is a major source of morbidity in the united states (u.s.), the incidence of diabetes has increased markedly over time , tracking closely with increasing rates of adiposity , decreasing amounts of physical activity , and aging of the population. given the substantial incidence rates of both diabetes and prostate cancer, any relation of diabetes to the risk or severity of prostate cancer would have significant public health relevance. we examined the association between history of diabetes and prostate cancer risk in the prostate, lung, colorectal, and ovarian (plco) cancer study. we sought to examine this relationship stratified according to body mass and physical activity, variables closely related to glucose metabolism. a further goal was to investigate whether the association between diabetes and prostate cancer varied by psa level; the availability of comprehensive, prospective information on psa concentration allowed us to assess the influence of prostate cancer screening on the relation of diabetes to prostate cancer.\n",
      "\n",
      "\n",
      "objective:  \n",
      "methods:  we prospectively examined the diabetes–prostate cancer risk relationship among 33,088 men in the screening arm of the prostate, lung, colorectal and ovarian (plco) cancer screening trial.\n",
      "\n",
      "diabetes history was related to decreased risk of total prostate cancer (rr = 0.80, 95% ci = 0.68–0.95). the apparent protection afforded by diabetes was primarily due to the inverse relation with non-aggressive disease (i.e., the combination of low grade (gleason sum <8) and low stage (clinical stages i or ii); rr = 0.75; 95% ci = 0.62–0.91). in contrast, no association was noted between diabetes and aggressive disease (i.e., high grade or high stage (gleason sum ≥8 or clinical stages iii or iv); rr = 1.04, 95% ci = 0.74–1.45). in further analyses, the association between diabetes and aggressive prostate cancer was suggestively positive for men who were lean (rr = 1.64, 95% ci = 0.87–3.07; bmi < 25 kg/m) and it was positive for men who were the most physically active (rr = 1.63; 95% ci = 1.07–2.62; 3+ hours vigorous activity/week). by comparison, no relations of diabetes to aggressive prostate cancer were noted for their heavier or physically less active counterparts (p-value for tests of interaction = 0.10 and 0.03 bmi and physical activity, respectively).\n",
      "\n",
      "this study was conducted in the prostate, lung, colorectal, and ovarian (plco) cancer screening trial, a randomized controlled, multi-site study (birmingham, al; denver, co; detroit, mi; honolulu, hi; marshfield, wi; minneapolis, mn; pittsburgh, pa; salt lake city, ut; st louis, mo; and washington, dc) designed to evaluate selected methods for the early detection of these four cancers . between 1993 and 2001, 38,350 men aged 55–74 years were randomized to the screening arm of the trial. these men received a prostate-specific antigen (psa) test and a digital rectal exam (dre) at study entry annually for three years, followed by two years of screening with psa only. men with a psa test result of >4 ng/ml or dre suspicious for prostate cancer were referred to their medical care providers for follow-up. in addition, each participant was asked to complete a baseline questionnaire and annual follow-up questionnaires regarding cancer diagnoses. out of 38,350 men who were randomly assigned to the screening arm of the trial, we excluded at baseline, men who reported a history of cancer other than non-melanoma skin cancer (n = 1,424); men without an initial psa test or dre (n = 2,470); men who received an initial screening examination but with whom there was no subsequent contact (n = 1,045); men who did not complete the baseline questionnaire (n = 898); men whose initial screening examination occurred after 30 september 2002, the censor date for the present analysis (n = 72); and men with missing values for history of diabetes (n = 1,302). after exclusions, the analytic cohort comprised 33,088 men (some participants were included in more than one exclusion category).\n",
      "\n",
      "for men with suspected prostate cancer or for those who reported prostate cancer on their annual questionnaire, we requested medical records to confirm the diagnosis and to obtain stage and grade information. we used death certificates, autopsy reports, and supporting medical/pathological records to confirm the information regarding diagnosis, stage, and grade for participants who were deceased. clinical stage i and ii tumors (stage i tumor = occult or incidental finding; stage ii tumor = confined to prostate) with gleason sum <8 were defined as non-aggressive. clinical stage iii and iv tumors (stage iii tumor = localized to periprostatic area; stage iv tumor = metastatic disease) and/or tumors with biopsy gleason sum ≥8 were considered aggressive. we also distinguished between high-grade disease (defined as gleason sum ≥8) and high-stage disease (defined as stages iii or iv). out of 2,058 total cases, 1,239 (60%) were gleason sum <7, 596 (29%) were gleason sum = 7, and 189 (9%) were gleason sum ≥8. the majority of cases (n = 1,746, 85%) were clinical stages i or ii, and 307 cases (15%) were stages iii or iv. because prostate cancers with gleason 7 carry a greater risk of cancer progression than gleason 2–6 tumors, we conducted subanalyses using two alternate levels of low-grade prostate tumors: gleason ≤6 and gleason = 7.\n",
      "\n",
      "information on demographic and medical characteristics, anthropometry, and dietary intakes was collected using the baseline questionnaire. participants provided information on whether they had been told by a doctor that they had any of 19 listed medical conditions, one of which was diabetes. approximately 95% of all diabetes cases are type 2 ; for the purpose of our analysis, we considered a report of diabetes on the questionnaire to be type 2 diabetes. information on history of diabetes based on self-report has shown excellent agreement (97%) with medical records .\n",
      "\n",
      "person-years were calculated from the date of the baseline prostate cancer screen at study entry to the date of the most recently completed annual follow-up questionnaire, date of prostate cancer diagnosis, death, or 30 september 2002, whichever came first. we used cox proportional hazards regression analysis to estimate relative risks (rrs) and 95% confidence intervals (cis) of prostate cancer with age as the underlying time metric. we adjusted for body mass index (bmi, <18.5, 18.5–24.9, 25–29.9, and 30 kg/m or more), race (caucasian, african–american, asian/pacific islander, and other), study center (10 categories), family history of prostate cancer (yes/no), smoking status (never, current, and former), attained education (<12 years, 12 years or high school, post high school or college, and college graduation or more), aspirin use (<4 per month, 1–6 per week, 1 per day, and 2+ per day), physical activity (0, 1, 2, 3, 4, and 5 h per week or more), and height (<170, 170–174.9, 175–179.9, 180–184.9, 185–189.9, and 190 cm or more). more rigorous adjustment for bmi (i.e., using a continuous bmi variable) or additional control for intakes of lycopene, selenium supplements, vitamin e, zinc, calcium, dairy products, red meat, dietary fat, and alcohol did not alter the rr estimates. we examined whether the relation of diabetes to prostate cancer was modified by bmi (using categories of <25, 25–29.9, and 30 kg/m) and physical activity (using categories of <1, 1–2, and 3+ hours per week). we also conducted an exploratory evaluation of the impact of prostate cancer screening on the relationship of diabetes to prostate cancer by running stratified analyses according to level of psa at study entry (using categories of <4.0 and ≥4.0 ng/ml).\n",
      "\n",
      "\n",
      "results:  specifically, diabetes was inversely associated with early stage prostate cancer but it showed no relation with aggressive prostate cancer. exploratory analyses suggested a positive association between diabetes and aggressive prostate cancer in the subgroup of men with a low bmi.\n",
      "\n",
      "this study was conducted in the prostate, lung, colorectal, and ovarian (plco) cancer screening trial, a randomized controlled, multi-site study (birmingham, al; denver, co; detroit, mi; honolulu, hi; marshfield, wi; minneapolis, mn; pittsburgh, pa; salt lake city, ut; st louis, mo; and washington, dc) designed to evaluate selected methods for the early detection of these four cancers . between 1993 and 2001, 38,350 men aged 55–74 years were randomized to the screening arm of the trial. these men received a prostate-specific antigen (psa) test and a digital rectal exam (dre) at study entry annually for three years, followed by two years of screening with psa only. men with a psa test result of >4 ng/ml or dre suspicious for prostate cancer were referred to their medical care providers for follow-up. in addition, each participant was asked to complete a baseline questionnaire and annual follow-up questionnaires regarding cancer diagnoses. out of 38,350 men who were randomly assigned to the screening arm of the trial, we excluded at baseline, men who reported a history of cancer other than non-melanoma skin cancer (n = 1,424); men without an initial psa test or dre (n = 2,470); men who received an initial screening examination but with whom there was no subsequent contact (n = 1,045); men who did not complete the baseline questionnaire (n = 898); men whose initial screening examination occurred after 30 september 2002, the censor date for the present analysis (n = 72); and men with missing values for history of diabetes (n = 1,302). after exclusions, the analytic cohort comprised 33,088 men (some participants were included in more than one exclusion category). for men with suspected prostate cancer or for those who reported prostate cancer on their annual questionnaire, we requested medical records to confirm the diagnosis and to obtain stage and grade information. we used death certificates, autopsy reports, and supporting medical/pathological records to confirm the information regarding diagnosis, stage, and grade for participants who were deceased. clinical stage i and ii tumors (stage i tumor = occult or incidental finding; stage ii tumor = confined to prostate) with gleason sum <8 were defined as non-aggressive. clinical stage iii and iv tumors (stage iii tumor = localized to periprostatic area; stage iv tumor = metastatic disease) and/or tumors with biopsy gleason sum ≥8 were considered aggressive. we also distinguished between high-grade disease (defined as gleason sum ≥8) and high-stage disease (defined as stages iii or iv). out of 2,058 total cases, 1,239 (60%) were gleason sum <7, 596 (29%) were gleason sum = 7, and 189 (9%) were gleason sum ≥8. the majority of cases (n = 1,746, 85%) were clinical stages i or ii, and 307 cases (15%) were stages iii or iv. because prostate cancers with gleason 7 carry a greater risk of cancer progression than gleason 2–6 tumors, we conducted subanalyses using two alternate levels of low-grade prostate tumors: gleason ≤6 and gleason = 7. information on demographic and medical characteristics, anthropometry, and dietary intakes was collected using the baseline questionnaire. participants provided information on whether they had been told by a doctor that they had any of 19 listed medical conditions, one of which was diabetes. approximately 95% of all diabetes cases are type 2 ; for the purpose of our analysis, we considered a report of diabetes on the questionnaire to be type 2 diabetes. information on history of diabetes based on self-report has shown excellent agreement (97%) with medical records . person-years were calculated from the date of the baseline prostate cancer screen at study entry to the date of the most recently completed annual follow-up questionnaire, date of prostate cancer diagnosis, death, or 30 september 2002, whichever came first. we used cox proportional hazards regression analysis to estimate relative risks (rrs) and 95% confidence intervals (cis) of prostate cancer with age as the underlying time metric. we adjusted for body mass index (bmi, <18.5, 18.5–24.9, 25–29.9, and 30 kg/m or more), race (caucasian, african–american, asian/pacific islander, and other), study center (10 categories), family history of prostate cancer (yes/no), smoking status (never, current, and former), attained education (<12 years, 12 years or high school, post high school or college, and college graduation or more), aspirin use (<4 per month, 1–6 per week, 1 per day, and 2+ per day), physical activity (0, 1, 2, 3, 4, and 5 h per week or more), and height (<170, 170–174.9, 175–179.9, 180–184.9, 185–189.9, and 190 cm or more). more rigorous adjustment for bmi (i.e., using a continuous bmi variable) or additional control for intakes of lycopene, selenium supplements, vitamin e, zinc, calcium, dairy products, red meat, dietary fat, and alcohol did not alter the rr estimates. we examined whether the relation of diabetes to prostate cancer was modified by bmi (using categories of <25, 25–29.9, and 30 kg/m) and physical activity (using categories of <1, 1–2, and 3+ hours per week). we also conducted an exploratory evaluation of the impact of prostate cancer screening on the relationship of diabetes to prostate cancer by running stratified analyses according to level of psa at study entry (using categories of <4.0 and ≥4.0 ng/ml).\n",
      "\n",
      "we examined baseline characteristics of the study population according to diabetes history to assess the potential for confounding (table 1). men with a history of diabetes were less likely to report a family history of prostate cancer, they were less educated, and they drank less alcohol than men without a history of diabetes. in contrast, men with a history of diabetes were heavier, more sedentary, and more likely to use aspirin than men without a history of diabetes. men with and without a diabetes history were similarly likely at study entry to report having undergone a psa test during the past three years or having a previous history of prostate biopsy. however, men with a history of diabetes had a 14% lower baseline psa concentration than men without a history of diabetes. although the number of screening examinations during the trial did not vary by history of diabetes, the probability of undergoing prostate biopsy following an abnormal psa or dre test during the trial was lower among men with diabetes than men without diabetes. during 8.9 years follow-up of 33,088 men, 2,058 men were diagnosed with prostate cancer. in multivariate analysis, history of diabetes was associated with a statistically significant decreased risk of total prostate cancer (rr = 0.80, 95% ci = 0.68–0.95; table 2). the apparent protection afforded by diabetes was primarily due to the inverse relations with low grade or low stage prostate cancer; the rr for non-aggressive disease (i.e., low grade and low stage) was 0.75 (95% ci = 0.62–0.91). in contrast, no association was noted between diabetes and aggressive disease (i.e., high grade or high stage; rr = 1.04, 95% ci = 0.74–1.45). additional control for history of nocturia and history of bph did not alter risk estimates (rr for non-aggressive disease = 0.73; 95% ci = 0.60–0.89; rr for aggressive disease = 0.99; 95% ci = 0.71–1.37). results were similar when we excluded cases diagnosed during the first year of follow-up (rr for non-aggressive disease = 0.69; 95% ci = 0.55–0.88; rr for aggressive disease = 0.74; 95% ci = 0.44–1.24) or excluded cases diagnosed during the first three years of follow-up (rr for non-aggressive disease = 0.58; 95% ci = 0.40–0.83; rr for aggressive disease = 0.65; 95% ci = 0.30–1.43 based on 7 aggressive cases). overall results for low-grade prostate cancer were similar when we used two alternative definitions of low-grade disease. the rr between diabetes and prostate cancers with gleason sum ≤6 was 0.72 (95% ci = 0.57–0.90) and the rr between diabetes and prostate cancers with gleason sum = 7 was 0.88 (95% ci = 0.65–1.18). we examined whether the effect of diabetes on prostate cancer risk was modified by body mass and physical activity levels, variables closely related to glucose metabolism (table 3). the inverse association between diabetes and non-aggressive prostate cancer was largely similar across subgroups of bmi, and the inverse relation of diabetes to non-aggressive prostate cancer was somewhat marked among men with low physical activity levels. however, formal tests for interaction revealed that those differences were not statistically significant (p-value for tests of interaction >0.05). in contrast, the association between diabetes and aggressive prostate cancer was suggestively positive for men who were lean (rr = 1.64, 95% ci = 0.87–3.07; bmi < 25 kg/cm) and it was positive for men who were the most physically active (rr = 1.63; 95% ci = 1.07–2.62; 3+ hours vigorous activity/week). by comparison, no relations of diabetes to aggressive prostate cancer were noted for their heavier or physically less active counterparts (p-value for tests of interaction = 0.10 and 0.03 bmi and physical activity, respectively). we conducted an exploratory analysis restricting the sample to men who were psa negative (<4.0 ng/ml) at study entry (table 4). a marked inverse association between diabetes and total prostate cancer emerged (rr = 0.65, 95% ci = 0.51–0.83). in this subgroup analysis of psa-negative men, the inverse relation between diabetes and total prostate cancer held for both non-aggressive disease (rr = 0.64, 95% ci = 0.49–0.83) and aggressive disease (rr = 0.72, 95% ci = 0.41–1.27); statistical power was low in the latter analysis due to small number of cases. in contrast, in the small subgroup of men who were psa positive (≥4.0 ng/ml) at study entry, diabetes showed a weak positive association with total prostate cancer (rr = 1.27, 95% ci = 1.01–1.61). that relation was largely driven by the positive association with aggressive disease (rr = 1.76; 95% ci = 1.15–2.70), whereas the relation of diabetes to non-aggressive disease was null (rr = 1.12; 95% ci = 0.84–1.50). the observed positive relation with aggressive disease was largely determined by cases diagnosed within one year of the baseline screening examination (rr = 1.86, 95% ci = 1.15–3.01).\n",
      "\n",
      "the main result of the current study is that the history of diabetes was associated with a 20% decrease in risk of total prostate cancer. the apparent protection against prostate cancer afforded by diabetes appeared to be slightly stronger when we repeated our analyses using non-aggressive prostate cancer as the endpoint, showing a 25% decrease in risk. these findings are very similar to a recent meta-analysis that reported a 27% lower risk of prostate cancer among studies that were conducted in the post-psa screening era . in contrast to the inverse association between diabetes and total and non-aggressive prostate cancer observed in our study, we found no relation with diabetes when we repeated our analyses using aggressive prostate cancer as an alternative study outcome. in fact, when we addressed whether the relation of diabetes to aggressive prostate cancers varied by body mass and physical activity level, we noted a positive association with diabetes among men who were lean or physically active. thus, our data suggest that diabetes is inversely related to the initiation or detection of prostate cancer, but has little association with prostate cancer progression overall and may have a positive relation to prostate cancer aggressiveness in the particular setting of a low fat mass. our finding of a positive relation of diabetes to aggressive prostate cancer in men with low fat mass is in agreement with data showing a positive association between serum insulin and predominantly advanced prostate cancer in a lean chinese population [11, 12], and it is consistent with one investigation that noted a positive relation of fasting glucose to prostate cancer risk in a largely non-obese group of icelandic men . study found no overall association between serum insulin and prostate cancer but did observe a suggestive positive relation in the subgroup of men who were lean . a low or intermediate (as opposed to high) fat mass, also associated with higher physical activity level, has been hypothesized to provide a hormonal milieu supportive of prostate cancer development, such as high levels of testosterone, growth hormone, insulin-like growth factor-1, leptin, and low levels of estrogen . the possibility of an increased risk of aggressive disease among certain subgroups of men with diabetes is supported by data showing that men with a diagnosis of diabetes [16, 17] or those with elevated levels of post-load glucose  or insulin [19–21] have been found to present with prostate cancer at later stages or with higher gleason scores at diagnosis [20, 21], to have increased prostate cancer recurrence [22, 23], and to have greater prostate cancer death [16, 18, 19] than men with normal glucose metabolism. that the adverse effect of diabetes is probably limited to aggressive forms of prostate cancer is consistent with studies showing that c-peptide and a homeostatic model assessment of insulin resistance (homa-ir)  and fasting glucose  are inversely related to non-aggressive prostate cancer but suggestively positively associated with aggressive disease. it is worth pointing out that previous studies [25–29] examining the association between diabetes and aggressive prostate cancer either found no positive relation of diabetes to aggressive prostate cancer or reported a more pronounced inverse relation of diabetes to aggressive than non-aggressive prostate cancer. however, those studies [25–29] did not specifically evaluate the relation of diabetes to aggressive prostate cancer among lean or physically active men. in our study, results from an exploratory analyses showed that diabetes was positively associated with total and aggressive prostate cancer among the subgroup of men who were psa positive at baseline, particularly among cases diagnosed during the one-year interval following the baseline screening examination. this indicates that the baseline screening examination converted a greater proportion of previously undiagnosed prostate tumors to known aggressive prostate cancers among diabetic than non-diabetic men, a commonly observed phenomenon known as a lead time effect . the most likely explanation for the drop-off in the association between diabetes and aggressive prostate cancer we observed after one year on study is culling of aggressive cancers in the first screening round and the overall less aggressive nature of cancers found on subsequent rounds of screening. a similar pattern of elevated prostate cancer risk during the time period immediately following the diagnosis of diabetes and a decline in risk associated with diabetes during the subsequent time period can be found in numerous previous studies [16, 25, 27, 31, 32]. two recent surveys reported that psa levels are about 20% lower among men with, as opposed to those without, diabetes, independent of age, race/ethnicity, and body mass [33, 34], consistent with results from our study. one possible mechanism involves lower circulating androgen levels in diabetic men , causing a decrease in psa production via the androgen response element in the psa promoter region . because results of psa screening in conjunction with those from dre largely determine who receives a biopsy, and biopsy is a major determinant of prostate cancer diagnosis, decreased serum psa levels could plausibly be related to less prostate cancer detection among diabetic men. the lower psa among diabetics apparently holds even in the face of a potentially counterbalancing tendency: diabetes is associated with prostatic enlargement [37–39], and psa is positively correlated with prostate volume [9, 40, 41]. the prostate enlargement associated with diabetes may even enhance screening bias by rendering the detection of prostate cancer more difficult in diabetic men. because prostate cancer typically involves only a small proportion of the total gland, and comparatively smaller tissue is collected from a large prostate than a small prostate at biopsy, the probability of sampling from the cancer site is decreased [42–46]. any association between diabetes and prostate cancer would be spurious if prostate cancer diagnoses occurred less frequently among men who had diabetes coinciding with low psa values and lower probability of prostate cancer detection. most [28, 31, 47–70], but not all [16, 32] studies of diabetes and prostate cancer that were conducted before the use of psa screening [28, 47–64] or studies that were carried out in countries without universal psa screening [16, 31, 32, 65–70] found no association between diabetes and prostate cancer. in contrast, investigations that were conducted after the use of psa screening fairly consistently reported an inverse association between diabetes and prostate cancer [25–27, 29, 71–74]. a recent meta-analysis reported a null association in studies conducted in the pre-psa screening era (rr = 0.94; 95% ci = 0.85–1.03; diabetics versus non-diabetics), whereas an inverse relation was detected in studies conducted in the post-psa screening era (rr = 0.73; 95% ci = 0.64–0.83) . one possible reason for the observed heterogeneity in results between studies that were conducted in the pre-psa versus post-psa screening era is a true protective effect of diabetes on prostate cancer that was missed in studies in the pre-psa screening era. an alternative explanation is detection bias in studies conducted in the post-psa screening era. it is noteworthy that studies conducted in the pre-psa era may not be free of detection bias if the frequency of performing digital rectal examinations, the primary prostate cancer screening test during the pre-psa era, differed between men with and without diabetes. data regarding this possibility are sparse, but one study from the pre-psa era noted that 65% of prostate cancers diagnosed among men with diabetes were first reported on a death certificate, compared to 47% for men without diabetes . we lacked information on the diagnosis date of diabetes, but given the age range of study participants (55 to 74 years of age) and the mean age at diagnosis of diabetes among u.s. adults (46.7 years) , we estimate that the majority of study participants reporting the history of diabetes were probably diagnosed in excess of 10 years prior to entry. we were not able to determine whether the observed relations between diabetes and prostate cancer risk were explained by medications taken to treat diabetes rather than a biologic pathway associated with diabetes itself. we could not examine the relation of diabetes to prostate cancer among non-white men because our study lacked sufficient number of cases among non-white men. in summary, this study confirms an inverse relation between diabetes and risk for total and non-aggressive prostate cancer. in contrast, we found no association between diabetes and aggressive prostate cancer overall, but we did note a positive relation of diabetes to aggressive prostate cancer among the subset of men who were lean or were physically highly active. these results add support to very limited available evidence of potential growth effects of diabetes and its metabolic sequelae on aggressive prostate cancers, an impact that appears to be amplified in the setting of a low body fat mass. we also present data from exploratory analyses, requiring confirmation, for a direct association between diabetes and aggressive prostate cancer among the very small group of men who were psa-positive at study baseline. whether this finding is in part due to underdiagnosis of early prostate cancers with aggressive potential among men with diabetes is speculative. future studies may test the hypothesis that prostate cancer detection rates are lower among diabetics than non-diabetics and that low biopsy rates due to diminished psa concentrations among diabetic men are one possible explanation. should this possibility hold true, further work may clarify whether using a lower psa concentration as the cut-point for triggering prostate biopsy in diabetics is justified. additional research may also determine whether prostatic enlargement typically associated with diabetes potentially aggravates detection bias of prostate cancer among diabetic men.\n",
      "\n",
      "\n",
      "conclusions:  a history of diabetes has been fairly consistently related to a reduced prostate cancer risk, but previous investigations have not always addressed whether the relation with diabetes varies by prostate cancer aggressiveness or the association between diabetes and prostate cancer is modified by physical activity level and body mass, variables closely related to glucose metabolism.\n",
      "\n",
      "\n",
      "none:  \n"
     ]
    }
   ],
   "source": [
    "for i, row in df.iterrows():\n",
    "    if row['article_id'] == 'PMC641128':\n",
    "        print(\"background: \", row[\"background\"])\n",
    "        print(\"objective: \", row[\"objective\"])\n",
    "        print(\"methods: \", row[\"methods\"])\n",
    "        print(\"results: \", row[\"results\"])\n",
    "        print(\"conclusions: \", row[\"conclusions\"])\n",
    "        print(\"none: \", row[\"none\"])\n",
    "        break"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "a0127bf0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "the a5 segment aneurysms of the anterior cerebral artery are rare, approximately 0.5% of all intracranial aneurysms. they are small with a wide base located in the midline, with the domes mostly projecting upward or backward. the authors describe a unique case of a5 segment aneurysm, with the dome embedded into the body of the corpus callosum. this 41-year-old female was admitted to the neurology department for possible multiple sclerosis investigation. computed tomography angiogram (cta) revealed a 4-mm right-sided pericallosal artery aneurysm, with rare configuration, which was caudally projected, embedded into the body of the corpus callosum. the postoperative ct and cta showed no complication and successful occlusion of the aneurysm with no ischemia or hemorrhage in the corpus callosum. to the best of our knowledge, this is the first case of an aneurysm with this configuration. our rare case of a5 segment aneurysm demonstrates the importance of planning of the surgery, choosing the appropriate approach, and knowing the detailed anatomy of the region, as well as the necessity of microsurgical clipping of small unruptured adistas. the a5 segment aneurysms of anterior cerebral artery (aca) are rare, approximately 0.5% of all intracranial aneurysms (ia). they are small, with wide base, located in the midline, with the domes mostly projecting upward or backward. in this article, we present an unusual a5 segment aneurysm with the dome embedded into the body of the corpus callosum, which, to our knowledge, is the first such case in the literature. a 41-year-old healthy non-smoking caucasian female was admitted to the neurology department to be investigated for possible multiple sclerosis, vertigo, coordination problems, tingling, and numbness in her left arm. a computed tomography angiogram (cta) was performed, which showed a 4-mm right-sided pericallosal artery aneurysm, with a rare configuration [figure 1]. the larger of the two terminal branches made a loop within the corpus callosum, where the aneurysm originated from, that was caudally projected, embedded into the body of the corpus callosum, forming a “pouch” in it [figure 2]. the dimensions of the aneurysm were: height – 4.8 mm; width – 4 mm; neck – 2.8 mm; parent artery diameter – 1.1 mm; the depth of embedding into the corpus callosum – 7.7 mm. cta, 3d-ct, and artistic drawing, showing a 4 mm a5 segment aneurysm of the right aca with rare configuration. sagittal image (a), 3d reconstruction (b), and artistic drawing (c), showing the aneurysm (arrows) sagittal mra image showing the aneurysm imbedded into the body of the corpus callosum (arrow) considering the family history (mother and uncle from mother's side died from aneurysmal sah in their forties), the patient was motivated for prophylactic ligation surgery. the patient was placed in a supine position, with the head fixed in a head frame. the head was elevated 20° above the heart level in neutral position with the nose pointing upward and somewhat flexed. because of the presence of a bridging vein at the shortest trajectory projection of the aneurysm to the scull convex that was visualized at the preoperative cta and magnetic resonance angiogram (mra), the approach was planned frontally to the vein [figure 3]. a right paramedian frontal craniotomy was performed with bone flap placed slightly over the midline to allow better retraction of the falx medially. the dura was opened under the operating microscope as a c-shaped flap with its base at the superior sagittal sinus. after clearing the arachnoid bands interhemispheric dissection was directed along the falx toward the corpus callosum. the smaller branch of the a4 bifurcation was revealed, which was directed backward and upward. afterward, the a4 bifurcation and the parent artery were determined beneath the smaller branch. the origin of the aneurysm was visualized, with its dome embedded into the body of the corpus callosum [figure 4a and b]. following careful dissection, a pilot clip was inserted to the aneurysm dome, which after reshaping of the dome by bipolar coagulation, was changed for a final clip [figure 4c]. the second clip was applied proximal to the first one for final closure of the slightly exposed neck. for intraoperative verification of clipping, an indocyanine green (icg) angiography was used. axial mra image showing the bridging vein at the shortest trajectory projection of the aneurysm to the scull convex (arrow) intraoperative view of parent artery (a) and the origin of the aneurysm, with its dome embedded into the body of the corpus callosum (b, arrows). the final clip was inserted after reshaping of the dome by bipolar coagulation (c, arrow) after transferring to the intensive care unit, the patient was oriented, without any signs of neurological deficit. at first postoperative day, ct and cta was performed, that showed no complication and successful occlusion of the aneurysm with no ischemia or hemorrhage in the corpus callosum. according to fischer, the aca can be divided into 5 segments, namely, a1 to a5. the a4 and a5 are the horizontal segments of the aca, running on the superior surface of the corpus callosum backwards in the pericallosal cistern, towards the splenum of the corpus callosum, with the coronary suture as a division point between them. aneurysms of the a4 and a5 segments of the aca are rare, forming approximately 0.5% of all ias. the most common sites for the adistas are the a4 segment and the distal callosomarginal artery (cma). the adistas are located in the midline, often above the free margin of the falx, which influences the side of the approach. the domes of most aneurysms distal to a3 segment of anterior cerebral artery (adistas) are projecting either upward or backward in the sagittal view. the main goal of the surgery of adistas is to select appropriate approach, locate the aneurysm inside the interhemispheric fissure, and to clip the neck without obstructing branches. because of the small size, deep location of the aneurysm, absence of any significant landmarks, it is extremely difficult to orientate inside the interhemispheric fissure and localize the aneurysm, working in the narrow corridor. therefore, it is very important to carefully study preoperative images and to form a clear vision of a detailed course of the surgery. a4 segment and anterior portion of the a5 segment and the cma are located below the free edge of the falx, which allows to shift the branches between two hemispheres and complicate the exposure of the adistas. critical attention should be paid to this during the dissection towards the aneurysm, preventing the damage of shifting branches. a4-a5 segment aneurysms are located superior to the corpus callosum, thus the surgical approach could be chosen with the shortest distance projection on the skull convex regarding the interhemispheric approach. however, the bone flap should be made taking into account the venous barriers, thus correcting the trajectory of the corridor. to the best of our knowledge, this is the first case of an aneurysm with this configuration. our rare case of a5 segment aneurysm demonstrates the importance of planning of the surgery, choosing the appropriate approach, and knowing the detailed anatomy of the region, as well as the necessity of microsurgical clipping of small unruptured adistas.  \n",
      "['the a5 segment aneurysms of the anterior cerebral artery are rare, approximately 0.5% of all intracranial aneurysms. they are small with a wide base located in the midline, with the domes mostly projecting upward or backward.', 'the authors describe a unique case of a5 segment aneurysm, with the dome embedded into the body of the corpus callosum. this 41-year-old female was admitted to the neurology department for possible multiple sclerosis investigation. computed tomography angiogram (cta) revealed a 4-mm right-sided pericallosal artery aneurysm, with rare configuration, which was caudally projected, embedded into the body of the corpus callosum. the postoperative ct and cta showed no complication and successful occlusion of the aneurysm with no ischemia or hemorrhage in the corpus callosum.', 'to the best of our knowledge, this is the first case of an aneurysm with this configuration. our rare case of a5 segment aneurysm demonstrates the importance of planning of the surgery, choosing the appropriate approach, and knowing the detailed anatomy of the region, as well as the necessity of microsurgical clipping of small unruptured adistas.', 'the a5 segment aneurysms of anterior cerebral artery (aca) are rare, approximately 0.5% of all intracranial aneurysms (ia). they are small, with wide base, located in the midline, with the domes mostly projecting upward or backward. in this article, we present an unusual a5 segment aneurysm with the dome embedded into the body of the corpus callosum, which, to our knowledge, is the first such case in the literature.', \"a 41-year-old healthy non-smoking caucasian female was admitted to the neurology department to be investigated for possible multiple sclerosis, vertigo, coordination problems, tingling, and numbness in her left arm. a computed tomography angiogram (cta) was performed, which showed a 4-mm right-sided pericallosal artery aneurysm, with a rare configuration [figure 1]. the larger of the two terminal branches made a loop within the corpus callosum, where the aneurysm originated from, that was caudally projected, embedded into the body of the corpus callosum, forming a “pouch” in it [figure 2]. the dimensions of the aneurysm were: height – 4.8 mm; width – 4 mm; neck – 2.8 mm; parent artery diameter – 1.1 mm; the depth of embedding into the corpus callosum – 7.7 mm. cta, 3d-ct, and artistic drawing, showing a 4 mm a5 segment aneurysm of the right aca with rare configuration. sagittal image (a), 3d reconstruction (b), and artistic drawing (c), showing the aneurysm (arrows) sagittal mra image showing the aneurysm imbedded into the body of the corpus callosum (arrow) considering the family history (mother and uncle from mother's side died from aneurysmal sah in their forties), the patient was motivated for prophylactic ligation surgery. the patient was placed in a supine position, with the head fixed in a head frame. the head was elevated 20° above the heart level in neutral position with the nose pointing upward and somewhat flexed. because of the presence of a bridging vein at the shortest trajectory projection of the aneurysm to the scull convex that was visualized at the preoperative cta and magnetic resonance angiogram (mra), the approach was planned frontally to the vein [figure 3]. a right paramedian frontal craniotomy was performed with bone flap placed slightly over the midline to allow better retraction of the falx medially. the dura was opened under the operating microscope as a c-shaped flap with its base at the superior sagittal sinus. after clearing the arachnoid bands interhemispheric dissection was directed along the falx toward the corpus callosum. the smaller branch of the a4 bifurcation was revealed, which was directed backward and upward. afterward, the a4 bifurcation and the parent artery were determined beneath the smaller branch. the origin of the aneurysm was visualized, with its dome embedded into the body of the corpus callosum [figure 4a and b]. following careful dissection, a pilot clip was inserted to the aneurysm dome, which after reshaping of the dome by bipolar coagulation, was changed for a final clip [figure 4c]. the second clip was applied proximal to the first one for final closure of the slightly exposed neck. for intraoperative verification of clipping, an indocyanine green (icg) angiography was used. axial mra image showing the bridging vein at the shortest trajectory projection of the aneurysm to the scull convex (arrow) intraoperative view of parent artery (a) and the origin of the aneurysm, with its dome embedded into the body of the corpus callosum (b, arrows). the final clip was inserted after reshaping of the dome by bipolar coagulation (c, arrow) after transferring to the intensive care unit, the patient was oriented, without any signs of neurological deficit. at first postoperative day, ct and cta was performed, that showed no complication and successful occlusion of the aneurysm with no ischemia or hemorrhage in the corpus callosum.\", 'according to fischer, the aca can be divided into 5 segments, namely, a1 to a5. the a4 and a5 are the horizontal segments of the aca, running on the superior surface of the corpus callosum backwards in the pericallosal cistern, towards the splenum of the corpus callosum, with the coronary suture as a division point between them. aneurysms of the a4 and a5 segments of the aca are rare, forming approximately 0.5% of all ias. the most common sites for the adistas are the a4 segment and the distal callosomarginal artery (cma). the adistas are located in the midline, often above the free margin of the falx, which influences the side of the approach. the domes of most aneurysms distal to a3 segment of anterior cerebral artery (adistas) are projecting either upward or backward in the sagittal view. the main goal of the surgery of adistas is to select appropriate approach, locate the aneurysm inside the interhemispheric fissure, and to clip the neck without obstructing branches. because of the small size, deep location of the aneurysm, absence of any significant landmarks, it is extremely difficult to orientate inside the interhemispheric fissure and localize the aneurysm, working in the narrow corridor. therefore, it is very important to carefully study preoperative images and to form a clear vision of a detailed course of the surgery. a4 segment and anterior portion of the a5 segment and the cma are located below the free edge of the falx, which allows to shift the branches between two hemispheres and complicate the exposure of the adistas. critical attention should be paid to this during the dissection towards the aneurysm, preventing the damage of shifting branches. a4-a5 segment aneurysms are located superior to the corpus callosum, thus the surgical approach could be chosen with the shortest distance projection on the skull convex regarding the interhemispheric approach. however, the bone flap should be made taking into account the venous barriers, thus correcting the trajectory of the corridor.', 'to the best of our knowledge, this is the first case of an aneurysm with this configuration. our rare case of a5 segment aneurysm demonstrates the importance of planning of the surgery, choosing the appropriate approach, and knowing the detailed anatomy of the region, as well as the necessity of microsurgical clipping of small unruptured adistas.', '', '']\n",
      "28217397\n"
     ]
    }
   ],
   "source": [
    "for i, row in df.iterrows():\n",
    "    if row['article_id'] == 'PMC530944':\n",
    "        print(row[\"full_text\"])\n",
    "        print(row[\"sections\"])\n",
    "        print(row[\"pmid\"])\n",
    "        break"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "78130395",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "we are delighted to announce the 2020 recipients of the ming k. jeang award for excellence in cell & bioscience. three research groups, who each published an outstanding research article in cell & bioscience in 2020 [1–3], have been selected to receive this prestigious award by a panel of editors, chaired by dr. the ming k. jeang awards for excellence in cell & bioscience was established in 2011 with a generous endowment from the ming k. jeang foundation to honor outstanding research articles published in cell & bioscience, the society journal of the society for chinese bioscientists in america (scba), a non-profit scientific society, based in north america, https://scbasociety.org/. the selected articles are listed as below. senolytic compounds control a distinct fate of androgen receptor agonist and antagonist‑induced cellular senescent lncap prostate cancer cells. thanakorn pungsrinont, malika franziska sutter, maren c. c. m. ertingshausen, gopinath lakshmana, miriam kokal, amir saeed khan and aria baniahmad. jing cai, meng zhang, yutong liu, huihui li, longcheng shang, tianze xu, zhipeng chen, fudi wang, tong qiao and kuanyu li. congratulations to these three groups of investigators for publishing their outstanding research results in cell & bioscience and winning the 2020 ming k. jeang award. we are looking forwards to receiving contributions of outstanding research articles and reviews from the scientific community in 2020 and beyond.\n",
      "['we are delighted to announce the 2020 recipients of the ming k. jeang award for excellence in cell & bioscience. three research groups, who each published an outstanding research article in cell & bioscience in 2020 [1–3], have been selected to receive this prestigious award by a panel of editors, chaired by dr. the ming k. jeang awards for excellence in cell & bioscience was established in 2011 with a generous endowment from the ming k. jeang foundation to honor outstanding research articles published in cell & bioscience, the society journal of the society for chinese bioscientists in america (scba), a non-profit scientific society, based in north america, https://scbasociety.org/. the selected articles are listed as below. senolytic compounds control a distinct fate of androgen receptor agonist and antagonist‑induced cellular senescent lncap prostate cancer cells. thanakorn pungsrinont, malika franziska sutter, maren c. c. m. ertingshausen, gopinath lakshmana, miriam kokal, amir saeed khan and aria baniahmad. jing cai, meng zhang, yutong liu, huihui li, longcheng shang, tianze xu, zhipeng chen, fudi wang, tong qiao and kuanyu li. congratulations to these three groups of investigators for publishing their outstanding research results in cell & bioscience and winning the 2020 ming k. jeang award. we are looking forwards to receiving contributions of outstanding research articles and reviews from the scientific community in 2020 and beyond.']\n",
      "34906230\n"
     ]
    }
   ],
   "source": [
    "for i, row in df.iterrows():\n",
    "    if row['article_id'] == 'PMC867248':\n",
    "        print(row[\"full_text\"])\n",
    "        print(row[\"sections\"])\n",
    "        print(row[\"pmid\"])\n",
    "        break"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b2536feb",
   "metadata": {},
   "outputs": [],
   "source": [
    "for i, row in df.iterrows():\n",
    "    if row['article_id'] == 'PMC867248':\n",
    "        print(row[\"full_text\"])\n",
    "        print(row[\"sections\"])\n",
    "        print(row[\"pmid\"])\n",
    "        break"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "854cd4eb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "the term transcriptome encompasses the complete set of rna molecules applying to an entire organism or specific cell type, making it more dynamic than the genome. two major classes of regulatory non-coding rnas (ncrnas) which lack any transcriptive capability include micrornas and long non-coding rnass (lncrnas). they play a significant role in diverse cellular processes from enabling normal development to disease progression, as well as cell communication. a valuable example of a biological carrier that can transport abundant quantities of lncrna is that of the exosome: a type of extracellular vesicle involved in cell-to-cell communication and disease transmission. its role has been documented in both physiological conditions and pathological changes such as cancer development, where they are responsible for the regulation of various processes including immunosuppression, proliferation and induction of pre-metastatic niche formation. in this review, the role of a number of exosomal lncrna molecules will be discussed. the first scientific report to examine the possibility that intracellular structures could be associated with the process of budding vesicles bearing receptors during maturation, using ferritin-labelled proteins and anti-igg, recorded the externalization of transferrin receptors into the intercellular space during sheep reticulocyte maturation (1). they belong to the group of membrane-derived vesicles known as extracellular vesicles (evs), together with oncosomes, ectosomes or apoptotic bodies (5). the classification of each vesicle to its specific group depends on genesis, composition, size and density (see table i). extracellular vesicles can be secreted constitutively or as a result of specific induction (6). the origin of exosomes is linked to the creation of multivesicular bodies (mvbs) in the endosomal pathway; mvbs are structures with a lipid bilayer and a density of 1.12–1.19 g/ml (7) and which display 5′ nucleotidase activity (8). exosomes are released from many types of healthy or tumour cells, although more abundantly in the latter (9), and can be found in the tumour microenvironment (tme) and blood samples of cancer patients (10). physiologically, exosomes can be found in urine (10), sperm (3), amniotic fluid (9) and various other biological fluids. the role of exosomes in metastasis, angiogenesis and epithelial-to-mesenchymal transition (emt) has been confirmed in cancer development by various studies (9). exosomes released by tumour cells were shown to constitute a leading source of antigens for dendritic cells inducing antitumour immune responses (11). the physiological functions of exosomes include cellular communication, immunity, infections, elimination of waste products and signalling (12). there is also evidence of their participation in aging-related diseases i.e. neurodegeneration when different types of mrnas, mirnas or lncrna change their abundance inside nanovesicles (13). exosome secretions and their molecular mechanisms are rather obscure, since their release is regulated by several signal molecules and various processes including ceramide synthesis and casignalling (3). proteins that interact with the cell membrane and perform lipid bilayer deformation are epsin, amphiphysin, endofilin, syndapin and dynamin (4). the biogenesis follows the following sequence: the process begins with membrane invagination and exosome release to cytoplasm, followed by early endosome (ee) formation, and then the formation of intraluminal vesicles (ilvs) inside the late endosome (le). under both normal and pathological conditions, exosomes have an endocytic origin and are released by different types of cells. although exosomes typically mimic the composition of the parent cells, they may contain a few signature proteins. following the formation of exosomes within the endocytic pathway, they are released from the plasma membrane via mvbs from early endosome maturation and may further fuse with lysosomes or the plasma membrane. the most common and well-known mechanism of cargo sorting is based on the action of proteins from endosomal sorting complex required for transport (escrt) (6). when this pathway is inactivated, there is a possibility to recruit sumoylated protein hnrnpa2b1 [it binds microrna (14)] or maintain the signal through tetraspanin-enriched microdomains (tems) composed of transmembrane glycoproteins (8,15). the most important proteins associated with escrt are: alix (alg-2-interacting protein x), syndecan and syntenin (16). syntenin ends the formation process through syndecan sorting and binding to alix, which affects escrt-iii (4). direct alix-syntenin interaction is possible through lypx(n)l motifs (16), which are observed in the viral proteins found in late assembly domains (l-domains), these being responsible for recruiting the host escrt machinery directly or via escrt-associated proteins. the final product of this escrt and auxiliary protein activity is the creation of an mvb containing exosomes. despite general syntenin-syndecan-alix axis, there are some other molecular individuals involved in controlling escrt. examples are adp-ribosylation factor 6 (arf6) gtpase and phospholipase d2 (pld2) enzyme which are considered as proteins associated with syntenin (17) and are responsible for the control of the budding of ilvs into mvbs (18). lip5 (lyst-interacting protein 5), also known as vesicle trafficking 1 protein (vta1), is a cofactor for vps4 atpase that enhances vps4-mediated disassembly of escrt-iii polymer (19). cep55 (centrosomal protein 55) can mediate alix and escrt-i complex recruitment; however, interactions with the components of escrt-ii and escrt-iii have also been observed (20). further examples consist of cd2ap (cd2-associated protein), iqgap1 (iq-motif-containing gtpase-activating protein 1) or rock1 (rho-associated kinase 1) which are thought to interact with alix or tsg-101 (tumor susceptibility gene 101). they participate in processes such as cytokinesis (20), viral budding (21) and cell polarity (22), respectively. finally, enzyme heparanase, able to internally cleave heparan sulfate chains on syndecans, acts by increasing exosome production by stimulating intraluminal budding of syndecan and syntenin (23). after the ‘mature’ multivesicular body is formed, it can be transported to lysosomes (degraded hydrolytic enzymes) or interact with the lipid membrane, resulting in exosome release outside the cell. in the latter case, the attachment of mvb to the lipid bilayer takes place with the help of rab-gtp and snare family proteins. following the fusion of mvb and cell membrane, the exosomes can be transported to distant areas of the organism (via blood vessels) or interact with neighbouring cells (4). ‘ targeted’ cells can internalize nanovesicles in endocytic way where the absorption itself is facilitated through phagocytosis, fusion with cell membrane or ligand-receptor interaction. 2 presents the process of biogenesis, secretion and absorption of exosomes by means of escrt machinery. nanovesicle formation exhibits some characteristic stages of biogenesis and involves specific structures present in the cell. the selective mechanism of transporting cargo to the exosome interior is a more heterogenous process, as evidenced by their varied content, even in different types and stages of cancer development (8). the composition of exosomes contains countless types of proteins, including cytokines and growth factors, lipids or nucleic acids (3), including characteristic biomarkers such as cd63, cd81, cd9, tsg-101, alix or hsp70 which allow direct identification of exosomes (6). the profile of the proteins within the vesicles consists of cytoplasmic proteins, cell membrane proteins or proteins from endosomes; however, no proteins from organelles have been detected (6). these proteins include a number of exosomal molecules, such as those connected with mvb biogenesis (e.g., alix, tsg-101) (6), escrt components (3), transport and fusion proteins (annexin, rab-gtp, flotillin) and heat shock cognate (hsc). the tumour exosomes (texs) include additional molecules that participate in the emt process including matrix metalloproteinases (mmps), il-6, tgf-β and immunosupression factors (fasl, trail and gal-9 that stimulates t cell apoptosis) (8). the lipid composition of exosomes is distinct from that of the cell membrane: it is rich in components such as cholesterol, sphingomyelin, glycerophospholipids, phosphatydylinositol, ceramide or phosphatidilserine, as well as prostaglandins and leukotrienes (6). the lipid content in exosomes is higher than that of the parent cell except phosphatidylcholine which is ordinarily decreased (24). an example of exosomal lipid activity is the differentiation of bone-marrow myeloid cells into myeloid-derived suppressor cells (mdscs) by prostaglandin e2. the accumulation of mdscs leads to immunosuppression, which provides favourable conditions for metastasis (8). the participation of lipids in the biogenesis of exosomes is summarized below (table iv). exosomes also can include different types of rna or dna such as mrna, mirna (6), lncrna, dsdna, rna-ror (regulator of reprogramming) (3), and therefore play a vital role in regulating signaling pathways and gene expression (refer to table v). these dna and rna molecules may be transferred into recipient cell by the fusion of exosome and cell membranes, aiding the regulation of large numbers of signaling pathways or expression of genes (3). many studies indicate elevated levels of lncrna in extracellular exosomes compared to parent cells (25,26). this can be attributed to the action of nucleotide patterns that are present in transcripts as cis-acting elements responsible for targeting them into exosomes (27). the purpose of this review is to highlight the significance of lncrna as a pivotal molecule inside exosomes. therefore, it will summarize the role of various exosomal lncrnas, together with their function in carcinogenesis and in other biological processes. nanovesicle formation exhibits some characteristic stages of biogenesis and involves specific structures present in the cell. the selective mechanism of transporting cargo to the exosome interior is a more heterogenous process, as evidenced by their varied content, even in different types and stages of cancer development (8). the composition of exosomes contains countless types of proteins, including cytokines and growth factors, lipids or nucleic acids (3), including characteristic biomarkers such as cd63, cd81, cd9, tsg-101, alix or hsp70 which allow direct identification of exosomes (6). the profile of the proteins within the vesicles consists of cytoplasmic proteins, cell membrane proteins or proteins from endosomes; however, no proteins from organelles have been detected (6). these proteins include a number of exosomal molecules, such as those connected with mvb biogenesis (e.g., alix, tsg-101) (6), escrt components (3), transport and fusion proteins (annexin, rab-gtp, flotillin) and heat shock cognate (hsc). the tumour exosomes (texs) include additional molecules that participate in the emt process including matrix metalloproteinases (mmps), il-6, tgf-β and immunosupression factors (fasl, trail and gal-9 that stimulates t cell apoptosis) (8). the lipid composition of exosomes is distinct from that of the cell membrane: it is rich in components such as cholesterol, sphingomyelin, glycerophospholipids, phosphatydylinositol, ceramide or phosphatidilserine, as well as prostaglandins and leukotrienes (6). the lipid content in exosomes is higher than that of the parent cell except phosphatidylcholine which is ordinarily decreased (24). an example of exosomal lipid activity is the differentiation of bone-marrow myeloid cells into myeloid-derived suppressor cells (mdscs) by prostaglandin e2. the accumulation of mdscs leads to immunosuppression, which provides favourable conditions for metastasis (8). the participation of lipids in the biogenesis of exosomes is summarized below (table iv). exosomes also can include different types of rna or dna such as mrna, mirna (6), lncrna, dsdna, rna-ror (regulator of reprogramming) (3), and therefore play a vital role in regulating signaling pathways and gene expression (refer to table v). these dna and rna molecules may be transferred into recipient cell by the fusion of exosome and cell membranes, aiding the regulation of large numbers of signaling pathways or expression of genes (3). many studies indicate elevated levels of lncrna in extracellular exosomes compared to parent cells (25,26). this can be attributed to the action of nucleotide patterns that are present in transcripts as cis-acting elements responsible for targeting them into exosomes (27). the purpose of this review is to highlight the significance of lncrna as a pivotal molecule inside exosomes. therefore, it will summarize the role of various exosomal lncrnas, together with their function in carcinogenesis and in other biological processes. nanovesicle formation exhibits some characteristic stages of biogenesis and involves specific structures present in the cell. the selective mechanism of transporting cargo to the exosome interior is a more heterogenous process, as evidenced by their varied content, even in different types and stages of cancer development (8). the composition of exosomes contains countless types of proteins, including cytokines and growth factors, lipids or nucleic acids (3), including characteristic biomarkers such as cd63, cd81, cd9, tsg-101, alix or hsp70 which allow direct identification of exosomes (6). the profile of the proteins within the vesicles consists of cytoplasmic proteins, cell membrane proteins or proteins from endosomes; however, no proteins from organelles have been detected (6). these proteins include a number of exosomal molecules, such as those connected with mvb biogenesis (e.g., alix, tsg-101) (6), escrt components (3), transport and fusion proteins (annexin, rab-gtp, flotillin) and heat shock cognate (hsc). the tumour exosomes (texs) include additional molecules that participate in the emt process including matrix metalloproteinases (mmps), il-6, tgf-β and immunosupression factors (fasl, trail and gal-9 that stimulates t cell apoptosis) (8). the lipid composition of exosomes is distinct from that of the cell membrane: it is rich in components such as cholesterol, sphingomyelin, glycerophospholipids, phosphatydylinositol, ceramide or phosphatidilserine, as well as prostaglandins and leukotrienes (6). the lipid content in exosomes is higher than that of the parent cell except phosphatidylcholine which is ordinarily decreased (24). an example of exosomal lipid activity is the differentiation of bone-marrow myeloid cells into myeloid-derived suppressor cells (mdscs) by prostaglandin e2. the accumulation of mdscs leads to immunosuppression, which provides favourable conditions for metastasis (8). the participation of lipids in the biogenesis of exosomes is summarized below (table iv). exosomes also can include different types of rna or dna such as mrna, mirna (6), lncrna, dsdna, rna-ror (regulator of reprogramming) (3), and therefore play a vital role in regulating signaling pathways and gene expression (refer to table v). these dna and rna molecules may be transferred into recipient cell by the fusion of exosome and cell membranes, aiding the regulation of large numbers of signaling pathways or expression of genes (3). many studies indicate elevated levels of lncrna in extracellular exosomes compared to parent cells (25,26). this can be attributed to the action of nucleotide patterns that are present in transcripts as cis-acting elements responsible for targeting them into exosomes (27). the purpose of this review is to highlight the significance of lncrna as a pivotal molecule inside exosomes. therefore, it will summarize the role of various exosomal lncrnas, together with their function in carcinogenesis and in other biological processes. the functional annotation of 60,770 full length longer cdnas and rare transcripts in the mouse transcriptome resulted in the discovery of a novel class of non-coding cdnas, among which ~80% of the transcripts are not spliced (28). the lncrnas constitute a class of transcripts that does not encode proteins and whose length exceeds 200 bp (29). this group includes several heterogenous molecules that are difficult to categorize: lncrnas can be divided into long intergenic non-coding rnas (lincrnas), long intronic non-coding rnas and half-stau1-binding site rnas (1/2sbsrnas) (30). depending on the dna coding strand, the lncrnas can be classified as sense or antisense transcripts (31). some resemblance can be found between mrnas and lncrnas in some biochemical processes, for example mechanisms of polyadenylation and splicing or participation of rna polymerase ii in the process of their transcription (32). the roles of these molecules are connected with transduction signal, decoys, guides or scaffolds (31); however, their main function is associated with their action as transcription regulators of protein-coding genes (32). there is also the probability that lncrnas act like a ‘sponge’-leading to mirna recruitment into evs, or possibly to provide the mechanisms required for microrna loading (13). these findings confirm both the diversity of lncrnas and their participation in carcinogenesis by demonstrating their influence on the promotion of angiogenesis, protein stability or mirna inhibition by acting as a sponge. in addition, as lncrnas are detected in texs or apoptotic bodies, and have high stability during circulation, they could be considered as potential cancer biomarkers (33); however, some studies indicate they may display tumour suppression behavior through the blocking of the transcription of apoptosis-inhibiting genes and stimulation of p53 expression (34) or the structural modification of chromatin (35). a classic feature of the tumour microenvironment is hypoxia, which has a notable impact on cancer progression. activation of its pathway via the transcription factor hypoxia inducible factor (hif) plays a part in metastasis and a more aggressive phenotype. the role of lncrnas in hypoxia-driven cancer progression came into view recently, where these hypoxia-responsive lncrnas play a critical part in regulating hypoxic gene expressions (36). hotair: hox transcript antisense rna has been associated with progression and poor prognosis in patients with squamous cell carcinoma (scc), hepatocellular carcinoma (hcc), urothelial bladder cancer (ubc) or colorectal cancer (crc) (37). yan et al (38) report the involvement of hotair in the repression of wif-1-a protein implicated in the wnt signaling pathway. moreover, epigenetic regulation is also achievable: it participates in the migration, invasion or proliferation, potentiating through silencing of mir-205 in bladder cancer. in addition, ubc cells displayed increased invasion with migration corresponding to regulation of the emt pathway, which was confirmed by knockdown of hotair. this resulted in reduced invasiveness by influencing genes connected with emt such as mmp1 (matrix metalloproteinase-1), zeb1 (zinc finger e-box-binding homeobox 1), twist1 (twist-related protein 1), snai1 (snail family zinc finger 1), zo-1 (zonula occludens 1), lamc2 (laminin, gamma 2), lamb3 (laminin, beta 3) or abl2 (abl proto-oncogene 2) (37). studies by xie et al, have shown that salivary hotair could be used as biomarker in diagnostics: it had good discriminatory power for differentiating pancreatic cancer from healthy patients and benign pancreatic tumour (39, 40). in addition to its contribution in cancerous diseases, hotair has also been described to play a role in rheumatoid arthritis, where its transcript activates mmp-2 and mmp-13 in synoviocytes and osteoclasts. furthermore, hotair-loaded exosomes with enriched lncrna activate macrophages and influence immune response (41). malat-1: metastasis-associated lung adenocarcinoma transcript 1 or nuclear-enriched abundant transcript 2 (neat-2) was the first lncrna to be associated with metastasis in non-small cell lung cancer (nsclc). this transcript, similar to the hotair lncrna, is also connected with migration or tumour growth induction. zhang et al (42), indicated increased expression of transcript compared to healthy controls, and an association with higher tnm stage in patients with cancer. in vitro study knockdown of malat-1 in cancer cell lines significantly inhibited cell proliferation and colony formation, although it also induced cell cycle arrest and cell apoptosis due to a decrease in s phase progression. in addition, cyclin d1 and cyclin d2 downregulation was also observed, suggesting that malat-1 was involved in acceleration of the cell cycle. this indicates that malat-1 can be an important therapeutic target when developing treatments for nsclc patients, because of its participation in the malignant phenotype of cancer through gene expression regulation (43). alongside nsclc, malat-1 has been proposed as a mediator of angiogenesis in thyroid cancer. huang et al (44), found it to play a role in the secretion of the fibroblast growth factor 2 (fgf) protein from tumour-associated macrophages (tams), which led to vascularization, promotion of proliferation, invasion and migration of cancer cells. nonetheless, malat-1 participation in releasing inflammatory cytokines or fgf2 secretion was predominantly blocked by overexpression of fgf2. zfas1: initial studies concerning the zinc finger antisense 1 (zfas1) lncrna refer to alveolar development in the mammary gland, with a proposed role in the regulation of alveolar development and epithelial cell differentiation in the mammary gland (45). the transcript has been found to promote cancer progression by cell cycle regulation through cyclin-dependent kinase 1 (cdk1) interaction or destabilization of the p53 protein. the level of zfas1 was also upregulated in exosomes from hcc, crc and gastric cancer (gc). pan et al (46), noticed that overexpression of this transcript leads to proliferation and migration of gc cells and zfas1-positive exosomes which can be internalized by mkn-28 cells. knockdown of zfas1 inhibited the migration, proliferation and emt process; however, it also induced cell cycle arrest and programmed cell death, serving as a potential tumour suppressor. these findings have been attributed to decreased erk, bcl-2 and increased bax protein levels. additionally, zfas1 knockdown was observed to suppress cell migration by decreasing the expression of emt transcription factors such as slug or twist. these findings suggest that zfas1 could promote metastasis by cell cycle acceleration or support emt playing a pivotal role in gc diagnosis (47). h19: h19 lncrna is also involved in tumor metastasis and has been described as a master factor in cancer biology due to its frequent deregulation in almost all tumours, both in the initiation and progression steps (48). h19 is connected with the downregulation of e-cadherin, which influences cell adhesion and leads to spread of cancer cells. in addition, conigliaro et al (49) investigated h19 as a pro-angiogenic molecule promoting cell-to-cell adhesion (cd90+ cells with endothelial cell monolayer) and association with increased expression of vegf and icam1 transcripts which in turn leads to new vessel development. h19 may also act as an epigenetic modulator or as mirna sponge (50). in conclusion, this type of lncrna could have a range of impacts on target cells and some of its functions still remain unknown; nevertheless, h19 has been proposed as a potential therapeutic target (e.g., in hcc) (51). pou3f3: in vitro studies indicate that this transcript increases viability and cell proliferation in gliomas and its overexpression is associated with tumour grading (52). hu et al (53) investigated whether exosomal pou3f3 from glioma cells could promote angiogenesis and its effect on endothelial cells. they indicate that lncrna enriched the exosomes regulating the migration, proliferation and angiogenesis of human brain microvascular endothelial cells (hbmecs) in both in vitro and in vivo studies. silencing pou3f3 using shrna decreased the migratory ability of endothelial cells but did not affect their motility. pou3f3 overexpression in hbmecs caused by lncrna enriched exosome internalization, and significantly upregulated the transcript level of bfgf, bfgfr, angio and vegfa. these findings indicate that pou3f3 lncrna can be an essential molecule in cell-to-cell communication or a regulator of angiogenesis in glioma cells (53). uces are 100% maintained genomic sequences that are greater than 200 bases in length and are conserved across human, mouse and rat genomes (54). the localization of these elements is connected with fragile sites and cancer-associated regions of the genome. a study on the role of exosomal ultraconserved lncrna in modulating target cell phenotype as a result of genomic changes found that tuc339 upregulation in hcc cell lines resulted in an enhancement of cell growth and a reduction of adhesion to cell-extracellular matrix (ecm). the knockdown of tuc339 decreased proliferation and altered the expression of a total of 843 genes, 469 of which were inhibited (56). ror: lncrna ror participates in liver cancer through disruption in tgf-β pathway. although tgf-β has been related to cancer chemoresistance, the molecular actions involved in this event remain unknown. takahashi et al (57), identified a possibly mechanism by which lncrna may mediate chemoresistance dependent on tgf-β. they indicate that tgf-β reduced the sensitivity of hcc cells to sorafenib or doxorubicin, with a further reduction of sorafenib-dependent caspase 3/7 activity, leading to inhibition of the apoptosis process. moreover, the release of extracellular vesicles and packaging of lncrna within vesicles were also modulated by tgf-β. one of the selectively enriched exosomal lncrnas thought to be a potential mediator of chemoresistance is rna-ror. using a molecular pathway connected with p53 dependent signaling, lincrna can contribute to tumor development by inhibiting apoptosis through the repression of p53. additionally, knockdown of this lncrna results in increased expression of caspase 8 and gadd45b, leading to apoptosis induction and growth arrest. these data suggest that lincrna ror can be an important mediator in cell-to-cell communication and its contribution in chemoresistance has been confirmed in research. inhibition of this transcript resulted in reversion of drug resistance, leading to cell death (58). vldlr: one of the long-intergenic non-coding rna transcripts that support hcc development is called vldlr (59). by showing that knockdown of this rna can result in cell cycle arrest in g1/s phase, takahashi et al (60), confirmed that it regulates hcc cell proliferation. moreover, the quantity of lncrna was increased in both hcc cells and extracellular vesicles following chemotherapeutic stress caused by sorafenib, doxorubicin and camptothecin, thus enhancing cell viability. furthermore, the extracellular transfer of vldlr to adjacent tumour cells could participate in chemoresistance through the modulation of abcg2 gene expression. the summary of the other lncrna molecules that participate in tumour development is presented in table vi. in contrast to the lncrnas with pro-cancerous properties, there is also another group of transcripts that could support normal cells rather than stimulating their conversion into a neoplastic phenotype (61). gas5: several studies have implied that the growth arrest specific 5 gene molecule has not been connected with cancer progression, as its expression has been observed to be reduced in various cancer types (62,63). pickard et al (64), noticed that gas5 participates in apoptosis regulation in prostate cancer cells. they indicated that the high expression of gas5 level reduces tumour cell survival and hence induces pro-apoptotic activity. on the other hand, when gas5 was downregulated, programmed cell death was diminished but growth arrest was not. in prostate carcinoma gas5 has been found to bind to the receptor domain and inhibit transcriptional stimulation, leading to increased death of tumour cells (65). particl: some studies also confirmed the role of lncrnas in the methylation process in response to radiation. one of this lncrna is particl (promoter of mat2a antisense radiation-induced circulating long non-coding rna) a trans-acting mediator of dna, and histone lysine methylation, a clever component for gene silencing (66). the findings indicate that in low dose irradiation, particl can enhance ezh2 (enhancer of zeste homolog 2) expression, which in turn catalyzes the addition of methyl groups to histone h3 at lysine 27. moreover, there was also an observed increase in the activity of the dnmt1 enzyme (dna methyltransferase 1), global methylome enhancement methylome regulation e.g., cpg island methylation of wwox gene. finally, speculation about particl as an epigenetic modifying platform targeting chromatin structure modulation through recruitment of prc2 (polycomb repressive complex 2) has been proposed; this has been proposed to act by the binding of lncrna to a subunit of prc2 called suz12 (suppressor of zeste 12). these data indicate that particl interlinks regulators of epigenetic modifications that may affect the suppression of transcription (67). ccnd1: another lncrna found in exosomes (68) and connected with ionizing radiation-dependent transcription (69) is ncrna ccnd1 (cyclin d1). this single strand transcript binds to the tls (translocated in liposarcoma) modulator, thus recruiting it to ccnd1 promoter and inducing negative regulation of gene transcription. in addition, it also blocks the activity of creb (camp response element binding) and p300 proteins. exo1-4: the four molecules that occur abundantly in exosomes in cervical cancer were defined as exo1-4 (70). those transcripts contain dnase hypersensitive regions as well as rnapii and ctcf binding sites (71). exo1-4 is a subset of lncrnas that modulate cell function through increasing recipient cell viability by binding to various proteins: for example, exo2 directly interacts with lactate dehydrogenase b (ldhb) while exo4 reacts with high mobility group protein 17 (hmg-17). this speculates that lncrna exo1-4 has an impact on processes like cell metabolism or nucleosomal architecture. because lncrna has greater tissue specificity than mrna (72), these molecules may act as specific diagnostic biomarkers (73). when included in extracellular vesicles, circulation of rna in body fluids is stable and able to resist the activity of ribonucleases (74), which makes them potential cancer prognostic markers (75). the profiles of lncrna varies depending on tumour types that may be useful for clinical research, and moreover, these molecules could replace biopsies owing to the reduced level of invasiveness (76). exosomal lncrna can be nominated as cancer biomarkers but some of them are responsible for the development of other diseases (77). a set of differently expressed lncrna associated with non-cancerous or cancerous diseases is shown in table vii. a classic feature of the tumour microenvironment is hypoxia, which has a notable impact on cancer progression. activation of its pathway via the transcription factor hypoxia inducible factor (hif) plays a part in metastasis and a more aggressive phenotype. the role of lncrnas in hypoxia-driven cancer progression came into view recently, where these hypoxia-responsive lncrnas play a critical part in regulating hypoxic gene expressions (36). hotair: hox transcript antisense rna has been associated with progression and poor prognosis in patients with squamous cell carcinoma (scc), hepatocellular carcinoma (hcc), urothelial bladder cancer (ubc) or colorectal cancer (crc) (37). yan et al (38) report the involvement of hotair in the repression of wif-1-a protein implicated in the wnt signaling pathway. moreover, epigenetic regulation is also achievable: it participates in the migration, invasion or proliferation, potentiating through silencing of mir-205 in bladder cancer. in addition, ubc cells displayed increased invasion with migration corresponding to regulation of the emt pathway, which was confirmed by knockdown of hotair. this resulted in reduced invasiveness by influencing genes connected with emt such as mmp1 (matrix metalloproteinase-1), zeb1 (zinc finger e-box-binding homeobox 1), twist1 (twist-related protein 1), snai1 (snail family zinc finger 1), zo-1 (zonula occludens 1), lamc2 (laminin, gamma 2), lamb3 (laminin, beta 3) or abl2 (abl proto-oncogene 2) (37). studies by xie et al, have shown that salivary hotair could be used as biomarker in diagnostics: it had good discriminatory power for differentiating pancreatic cancer from healthy patients and benign pancreatic tumour (39, 40). in addition to its contribution in cancerous diseases, hotair has also been described to play a role in rheumatoid arthritis, where its transcript activates mmp-2 and mmp-13 in synoviocytes and osteoclasts. furthermore, hotair-loaded exosomes with enriched lncrna activate macrophages and influence immune response (41). malat-1: metastasis-associated lung adenocarcinoma transcript 1 or nuclear-enriched abundant transcript 2 (neat-2) was the first lncrna to be associated with metastasis in non-small cell lung cancer (nsclc). this transcript, similar to the hotair lncrna, is also connected with migration or tumour growth induction. zhang et al (42), indicated increased expression of transcript compared to healthy controls, and an association with higher tnm stage in patients with cancer. in vitro study knockdown of malat-1 in cancer cell lines significantly inhibited cell proliferation and colony formation, although it also induced cell cycle arrest and cell apoptosis due to a decrease in s phase progression. in addition, cyclin d1 and cyclin d2 downregulation was also observed, suggesting that malat-1 was involved in acceleration of the cell cycle. this indicates that malat-1 can be an important therapeutic target when developing treatments for nsclc patients, because of its participation in the malignant phenotype of cancer through gene expression regulation (43). alongside nsclc, malat-1 has been proposed as a mediator of angiogenesis in thyroid cancer. huang et al (44), found it to play a role in the secretion of the fibroblast growth factor 2 (fgf) protein from tumour-associated macrophages (tams), which led to vascularization, promotion of proliferation, invasion and migration of cancer cells. nonetheless, malat-1 participation in releasing inflammatory cytokines or fgf2 secretion was predominantly blocked by overexpression of fgf2. zfas1: initial studies concerning the zinc finger antisense 1 (zfas1) lncrna refer to alveolar development in the mammary gland, with a proposed role in the regulation of alveolar development and epithelial cell differentiation in the mammary gland (45). the transcript has been found to promote cancer progression by cell cycle regulation through cyclin-dependent kinase 1 (cdk1) interaction or destabilization of the p53 protein. the level of zfas1 was also upregulated in exosomes from hcc, crc and gastric cancer (gc). pan et al (46), noticed that overexpression of this transcript leads to proliferation and migration of gc cells and zfas1-positive exosomes which can be internalized by mkn-28 cells. knockdown of zfas1 inhibited the migration, proliferation and emt process; however, it also induced cell cycle arrest and programmed cell death, serving as a potential tumour suppressor. these findings have been attributed to decreased erk, bcl-2 and increased bax protein levels. additionally, zfas1 knockdown was observed to suppress cell migration by decreasing the expression of emt transcription factors such as slug or twist. these findings suggest that zfas1 could promote metastasis by cell cycle acceleration or support emt playing a pivotal role in gc diagnosis (47). h19: h19 lncrna is also involved in tumor metastasis and has been described as a master factor in cancer biology due to its frequent deregulation in almost all tumours, both in the initiation and progression steps (48). h19 is connected with the downregulation of e-cadherin, which influences cell adhesion and leads to spread of cancer cells. in addition, conigliaro et al (49) investigated h19 as a pro-angiogenic molecule promoting cell-to-cell adhesion (cd90+ cells with endothelial cell monolayer) and association with increased expression of vegf and icam1 transcripts which in turn leads to new vessel development. h19 may also act as an epigenetic modulator or as mirna sponge (50). in conclusion, this type of lncrna could have a range of impacts on target cells and some of its functions still remain unknown; nevertheless, h19 has been proposed as a potential therapeutic target (e.g., in hcc) (51). pou3f3: in vitro studies indicate that this transcript increases viability and cell proliferation in gliomas and its overexpression is associated with tumour grading (52). hu et al (53) investigated whether exosomal pou3f3 from glioma cells could promote angiogenesis and its effect on endothelial cells. they indicate that lncrna enriched the exosomes regulating the migration, proliferation and angiogenesis of human brain microvascular endothelial cells (hbmecs) in both in vitro and in vivo studies. silencing pou3f3 using shrna decreased the migratory ability of endothelial cells but did not affect their motility. pou3f3 overexpression in hbmecs caused by lncrna enriched exosome internalization, and significantly upregulated the transcript level of bfgf, bfgfr, angio and vegfa. these findings indicate that pou3f3 lncrna can be an essential molecule in cell-to-cell communication or a regulator of angiogenesis in glioma cells (53). uces are 100% maintained genomic sequences that are greater than 200 bases in length and are conserved across human, mouse and rat genomes (54). the localization of these elements is connected with fragile sites and cancer-associated regions of the genome. a study on the role of exosomal ultraconserved lncrna in modulating target cell phenotype as a result of genomic changes found that tuc339 upregulation in hcc cell lines resulted in an enhancement of cell growth and a reduction of adhesion to cell-extracellular matrix (ecm). the knockdown of tuc339 decreased proliferation and altered the expression of a total of 843 genes, 469 of which were inhibited (56). ror: lncrna ror participates in liver cancer through disruption in tgf-β pathway. although tgf-β has been related to cancer chemoresistance, the molecular actions involved in this event remain unknown. takahashi et al (57), identified a possibly mechanism by which lncrna may mediate chemoresistance dependent on tgf-β. they indicate that tgf-β reduced the sensitivity of hcc cells to sorafenib or doxorubicin, with a further reduction of sorafenib-dependent caspase 3/7 activity, leading to inhibition of the apoptosis process. moreover, the release of extracellular vesicles and packaging of lncrna within vesicles were also modulated by tgf-β. one of the selectively enriched exosomal lncrnas thought to be a potential mediator of chemoresistance is rna-ror. using a molecular pathway connected with p53 dependent signaling, lincrna can contribute to tumor development by inhibiting apoptosis through the repression of p53. additionally, knockdown of this lncrna results in increased expression of caspase 8 and gadd45b, leading to apoptosis induction and growth arrest. these data suggest that lincrna ror can be an important mediator in cell-to-cell communication and its contribution in chemoresistance has been confirmed in research. inhibition of this transcript resulted in reversion of drug resistance, leading to cell death (58). vldlr: one of the long-intergenic non-coding rna transcripts that support hcc development is called vldlr (59). by showing that knockdown of this rna can result in cell cycle arrest in g1/s phase, takahashi et al (60), confirmed that it regulates hcc cell proliferation. moreover, the quantity of lncrna was increased in both hcc cells and extracellular vesicles following chemotherapeutic stress caused by sorafenib, doxorubicin and camptothecin, thus enhancing cell viability. furthermore, the extracellular transfer of vldlr to adjacent tumour cells could participate in chemoresistance through the modulation of abcg2 gene expression. the summary of the other lncrna molecules that participate in tumour development is presented in table vi. in contrast to the lncrnas with pro-cancerous properties, there is also another group of transcripts that could support normal cells rather than stimulating their conversion into a neoplastic phenotype (61). gas5: several studies have implied that the growth arrest specific 5 gene molecule has not been connected with cancer progression, as its expression has been observed to be reduced in various cancer types (62,63). pickard et al (64), noticed that gas5 participates in apoptosis regulation in prostate cancer cells. they indicated that the high expression of gas5 level reduces tumour cell survival and hence induces pro-apoptotic activity. on the other hand, when gas5 was downregulated, programmed cell death was diminished but growth arrest was not. in prostate carcinoma gas5 has been found to bind to the receptor domain and inhibit transcriptional stimulation, leading to increased death of tumour cells (65). particl: some studies also confirmed the role of lncrnas in the methylation process in response to radiation. one of this lncrna is particl (promoter of mat2a antisense radiation-induced circulating long non-coding rna) a trans-acting mediator of dna, and histone lysine methylation, a clever component for gene silencing (66). the findings indicate that in low dose irradiation, particl can enhance ezh2 (enhancer of zeste homolog 2) expression, which in turn catalyzes the addition of methyl groups to histone h3 at lysine 27. moreover, there was also an observed increase in the activity of the dnmt1 enzyme (dna methyltransferase 1), global methylome enhancement methylome regulation e.g., cpg island methylation of wwox gene. finally, speculation about particl as an epigenetic modifying platform targeting chromatin structure modulation through recruitment of prc2 (polycomb repressive complex 2) has been proposed; this has been proposed to act by the binding of lncrna to a subunit of prc2 called suz12 (suppressor of zeste 12). these data indicate that particl interlinks regulators of epigenetic modifications that may affect the suppression of transcription (67). ccnd1: another lncrna found in exosomes (68) and connected with ionizing radiation-dependent transcription (69) is ncrna ccnd1 (cyclin d1). this single strand transcript binds to the tls (translocated in liposarcoma) modulator, thus recruiting it to ccnd1 promoter and inducing negative regulation of gene transcription. in addition, it also blocks the activity of creb (camp response element binding) and p300 proteins. exo1-4: the four molecules that occur abundantly in exosomes in cervical cancer were defined as exo1-4 (70). those transcripts contain dnase hypersensitive regions as well as rnapii and ctcf binding sites (71). exo1-4 is a subset of lncrnas that modulate cell function through increasing recipient cell viability by binding to various proteins: for example, exo2 directly interacts with lactate dehydrogenase b (ldhb) while exo4 reacts with high mobility group protein 17 (hmg-17). this speculates that lncrna exo1-4 has an impact on processes like cell metabolism or nucleosomal architecture. because lncrna has greater tissue specificity than mrna (72), these molecules may act as specific diagnostic biomarkers (73). when included in extracellular vesicles, circulation of rna in body fluids is stable and able to resist the activity of ribonucleases (74), which makes them potential cancer prognostic markers (75). the profiles of lncrna varies depending on tumour types that may be useful for clinical research, and moreover, these molecules could replace biopsies owing to the reduced level of invasiveness (76). exosomal lncrna can be nominated as cancer biomarkers but some of them are responsible for the development of other diseases (77). a set of differently expressed lncrna associated with non-cancerous or cancerous diseases is shown in table vii. a classic feature of the tumour microenvironment is hypoxia, which has a notable impact on cancer progression. activation of its pathway via the transcription factor hypoxia inducible factor (hif) plays a part in metastasis and a more aggressive phenotype. the role of lncrnas in hypoxia-driven cancer progression came into view recently, where these hypoxia-responsive lncrnas play a critical part in regulating hypoxic gene expressions (36). hotair: hox transcript antisense rna has been associated with progression and poor prognosis in patients with squamous cell carcinoma (scc), hepatocellular carcinoma (hcc), urothelial bladder cancer (ubc) or colorectal cancer (crc) (37). yan et al (38) report the involvement of hotair in the repression of wif-1-a protein implicated in the wnt signaling pathway. moreover, epigenetic regulation is also achievable: it participates in the migration, invasion or proliferation, potentiating through silencing of mir-205 in bladder cancer. in addition, ubc cells displayed increased invasion with migration corresponding to regulation of the emt pathway, which was confirmed by knockdown of hotair. this resulted in reduced invasiveness by influencing genes connected with emt such as mmp1 (matrix metalloproteinase-1), zeb1 (zinc finger e-box-binding homeobox 1), twist1 (twist-related protein 1), snai1 (snail family zinc finger 1), zo-1 (zonula occludens 1), lamc2 (laminin, gamma 2), lamb3 (laminin, beta 3) or abl2 (abl proto-oncogene 2) (37). studies by xie et al, have shown that salivary hotair could be used as biomarker in diagnostics: it had good discriminatory power for differentiating pancreatic cancer from healthy patients and benign pancreatic tumour (39, 40). in addition to its contribution in cancerous diseases, hotair has also been described to play a role in rheumatoid arthritis, where its transcript activates mmp-2 and mmp-13 in synoviocytes and osteoclasts. furthermore, hotair-loaded exosomes with enriched lncrna activate macrophages and influence immune response (41). malat-1: metastasis-associated lung adenocarcinoma transcript 1 or nuclear-enriched abundant transcript 2 (neat-2) was the first lncrna to be associated with metastasis in non-small cell lung cancer (nsclc). this transcript, similar to the hotair lncrna, is also connected with migration or tumour growth induction. zhang et al (42), indicated increased expression of transcript compared to healthy controls, and an association with higher tnm stage in patients with cancer. in vitro study knockdown of malat-1 in cancer cell lines significantly inhibited cell proliferation and colony formation, although it also induced cell cycle arrest and cell apoptosis due to a decrease in s phase progression. in addition, cyclin d1 and cyclin d2 downregulation was also observed, suggesting that malat-1 was involved in acceleration of the cell cycle. this indicates that malat-1 can be an important therapeutic target when developing treatments for nsclc patients, because of its participation in the malignant phenotype of cancer through gene expression regulation (43). alongside nsclc, malat-1 has been proposed as a mediator of angiogenesis in thyroid cancer. huang et al (44), found it to play a role in the secretion of the fibroblast growth factor 2 (fgf) protein from tumour-associated macrophages (tams), which led to vascularization, promotion of proliferation, invasion and migration of cancer cells. nonetheless, malat-1 participation in releasing inflammatory cytokines or fgf2 secretion was predominantly blocked by overexpression of fgf2. zfas1: initial studies concerning the zinc finger antisense 1 (zfas1) lncrna refer to alveolar development in the mammary gland, with a proposed role in the regulation of alveolar development and epithelial cell differentiation in the mammary gland (45). the transcript has been found to promote cancer progression by cell cycle regulation through cyclin-dependent kinase 1 (cdk1) interaction or destabilization of the p53 protein. the level of zfas1 was also upregulated in exosomes from hcc, crc and gastric cancer (gc). pan et al (46), noticed that overexpression of this transcript leads to proliferation and migration of gc cells and zfas1-positive exosomes which can be internalized by mkn-28 cells. knockdown of zfas1 inhibited the migration, proliferation and emt process; however, it also induced cell cycle arrest and programmed cell death, serving as a potential tumour suppressor. these findings have been attributed to decreased erk, bcl-2 and increased bax protein levels. additionally, zfas1 knockdown was observed to suppress cell migration by decreasing the expression of emt transcription factors such as slug or twist. these findings suggest that zfas1 could promote metastasis by cell cycle acceleration or support emt playing a pivotal role in gc diagnosis (47). h19: h19 lncrna is also involved in tumor metastasis and has been described as a master factor in cancer biology due to its frequent deregulation in almost all tumours, both in the initiation and progression steps (48). h19 is connected with the downregulation of e-cadherin, which influences cell adhesion and leads to spread of cancer cells. in addition, conigliaro et al (49) investigated h19 as a pro-angiogenic molecule promoting cell-to-cell adhesion (cd90+ cells with endothelial cell monolayer) and association with increased expression of vegf and icam1 transcripts which in turn leads to new vessel development. h19 may also act as an epigenetic modulator or as mirna sponge (50). in conclusion, this type of lncrna could have a range of impacts on target cells and some of its functions still remain unknown; nevertheless, h19 has been proposed as a potential therapeutic target (e.g., in hcc) (51). pou3f3: in vitro studies indicate that this transcript increases viability and cell proliferation in gliomas and its overexpression is associated with tumour grading (52). hu et al (53) investigated whether exosomal pou3f3 from glioma cells could promote angiogenesis and its effect on endothelial cells. they indicate that lncrna enriched the exosomes regulating the migration, proliferation and angiogenesis of human brain microvascular endothelial cells (hbmecs) in both in vitro and in vivo studies. silencing pou3f3 using shrna decreased the migratory ability of endothelial cells but did not affect their motility. pou3f3 overexpression in hbmecs caused by lncrna enriched exosome internalization, and significantly upregulated the transcript level of bfgf, bfgfr, angio and vegfa. these findings indicate that pou3f3 lncrna can be an essential molecule in cell-to-cell communication or a regulator of angiogenesis in glioma cells (53). uces are 100% maintained genomic sequences that are greater than 200 bases in length and are conserved across human, mouse and rat genomes (54). the localization of these elements is connected with fragile sites and cancer-associated regions of the genome. a study on the role of exosomal ultraconserved lncrna in modulating target cell phenotype as a result of genomic changes found that tuc339 upregulation in hcc cell lines resulted in an enhancement of cell growth and a reduction of adhesion to cell-extracellular matrix (ecm). the knockdown of tuc339 decreased proliferation and altered the expression of a total of 843 genes, 469 of which were inhibited (56). ror: lncrna ror participates in liver cancer through disruption in tgf-β pathway. although tgf-β has been related to cancer chemoresistance, the molecular actions involved in this event remain unknown. takahashi et al (57), identified a possibly mechanism by which lncrna may mediate chemoresistance dependent on tgf-β. they indicate that tgf-β reduced the sensitivity of hcc cells to sorafenib or doxorubicin, with a further reduction of sorafenib-dependent caspase 3/7 activity, leading to inhibition of the apoptosis process. moreover, the release of extracellular vesicles and packaging of lncrna within vesicles were also modulated by tgf-β. one of the selectively enriched exosomal lncrnas thought to be a potential mediator of chemoresistance is rna-ror. using a molecular pathway connected with p53 dependent signaling, lincrna can contribute to tumor development by inhibiting apoptosis through the repression of p53. additionally, knockdown of this lncrna results in increased expression of caspase 8 and gadd45b, leading to apoptosis induction and growth arrest. these data suggest that lincrna ror can be an important mediator in cell-to-cell communication and its contribution in chemoresistance has been confirmed in research. inhibition of this transcript resulted in reversion of drug resistance, leading to cell death (58). vldlr: one of the long-intergenic non-coding rna transcripts that support hcc development is called vldlr (59). by showing that knockdown of this rna can result in cell cycle arrest in g1/s phase, takahashi et al (60), confirmed that it regulates hcc cell proliferation. moreover, the quantity of lncrna was increased in both hcc cells and extracellular vesicles following chemotherapeutic stress caused by sorafenib, doxorubicin and camptothecin, thus enhancing cell viability. furthermore, the extracellular transfer of vldlr to adjacent tumour cells could participate in chemoresistance through the modulation of abcg2 gene expression. the summary of the other lncrna molecules that participate in tumour development is presented in table vi. in contrast to the lncrnas with pro-cancerous properties, there is also another group of transcripts that could support normal cells rather than stimulating their conversion into a neoplastic phenotype (61). gas5: several studies have implied that the growth arrest specific 5 gene molecule has not been connected with cancer progression, as its expression has been observed to be reduced in various cancer types (62,63). pickard et al (64), noticed that gas5 participates in apoptosis regulation in prostate cancer cells. they indicated that the high expression of gas5 level reduces tumour cell survival and hence induces pro-apoptotic activity. on the other hand, when gas5 was downregulated, programmed cell death was diminished but growth arrest was not. in prostate carcinoma gas5 has been found to bind to the receptor domain and inhibit transcriptional stimulation, leading to increased death of tumour cells (65). particl: some studies also confirmed the role of lncrnas in the methylation process in response to radiation. one of this lncrna is particl (promoter of mat2a antisense radiation-induced circulating long non-coding rna) a trans-acting mediator of dna, and histone lysine methylation, a clever component for gene silencing (66). the findings indicate that in low dose irradiation, particl can enhance ezh2 (enhancer of zeste homolog 2) expression, which in turn catalyzes the addition of methyl groups to histone h3 at lysine 27. moreover, there was also an observed increase in the activity of the dnmt1 enzyme (dna methyltransferase 1), global methylome enhancement methylome regulation e.g., cpg island methylation of wwox gene. finally, speculation about particl as an epigenetic modifying platform targeting chromatin structure modulation through recruitment of prc2 (polycomb repressive complex 2) has been proposed; this has been proposed to act by the binding of lncrna to a subunit of prc2 called suz12 (suppressor of zeste 12). these data indicate that particl interlinks regulators of epigenetic modifications that may affect the suppression of transcription (67). ccnd1: another lncrna found in exosomes (68) and connected with ionizing radiation-dependent transcription (69) is ncrna ccnd1 (cyclin d1). this single strand transcript binds to the tls (translocated in liposarcoma) modulator, thus recruiting it to ccnd1 promoter and inducing negative regulation of gene transcription. in addition, it also blocks the activity of creb (camp response element binding) and p300 proteins. exo1-4: the four molecules that occur abundantly in exosomes in cervical cancer were defined as exo1-4 (70). those transcripts contain dnase hypersensitive regions as well as rnapii and ctcf binding sites (71). exo1-4 is a subset of lncrnas that modulate cell function through increasing recipient cell viability by binding to various proteins: for example, exo2 directly interacts with lactate dehydrogenase b (ldhb) while exo4 reacts with high mobility group protein 17 (hmg-17). this speculates that lncrna exo1-4 has an impact on processes like cell metabolism or nucleosomal architecture. because lncrna has greater tissue specificity than mrna (72), these molecules may act as specific diagnostic biomarkers (73). when included in extracellular vesicles, circulation of rna in body fluids is stable and able to resist the activity of ribonucleases (74), which makes them potential cancer prognostic markers (75). the profiles of lncrna varies depending on tumour types that may be useful for clinical research, and moreover, these molecules could replace biopsies owing to the reduced level of invasiveness (76). exosomal lncrna can be nominated as cancer biomarkers but some of them are responsible for the development of other diseases (77). a set of differently expressed lncrna associated with non-cancerous or cancerous diseases is shown in table vii. as a result of maintaining full stability of lncrna in extracellular vesicles as mentioned earlier, these transcripts can be taken up by target cells with their full functionality preserved (78). this make evs effective nanocarriers that are capable of regulating lncrnas expression in cancer cells (79). an attractive potential tumour therapy that requires further development maintaining high levels of tumour suppressor lncrnas or destabilizing oncogenic ones (80). h19 is an example of the use of pro-tumorigenic long non-coding transcripts in the specific targeting of tumour cells. the regulatory sequence of this lncrna was used in the successful formation of the bc-819 plasmid. in vivo this construct encodes the toxin diphtheria toxin a (dta) which provided encouraging results in the treatment of bladder or colon cancer, as well as pancreas carcinoma or nsclc (81). there are also potential approaches to inducing overexpression of lncrna meg3 (maternally expressed gene 3) in lung adenocarcinoma in order to increase sensitivity to cisplatin-based chemotherapy (82). another potential type of lncrna-based therapy exploits the ‘sponge’ activity of those transcripts, resulting in lowered mirna activity in tumours (81). even following the identification of numerous lncrnas connected with various diseases, there is still the need to identify more transcripts and clarify their mechanism of action. unbiased genetic screening, lncrna expression patterns and characterization of associated proteins should provide guidance. moreover, the development of better technologies directed to improve lncrna-based therapies will effectively expand their usage as therapeutic or diagnostic strategies. finally, investigation of new tools using the epigenetic functionality of lncrnas could help in the research and treatment of diseases that depend on epigenetics (83). when it comes to the development of exosomal lncrna-based therapeutics, a few problems were identified including uncertain functionality in biological pathways, the pharmacokinetics and toxicity of lncrnas and the precise quantification of ev-bounded non-coding transcripts which need to be addressed accordingly (84). in conclusion, progressive studies of lncrna properties can lead to their use as cancer biomarkers with high sensitivity and accuracy, resulting in early-stage detection, and improved performance of existing clinical biomarkers. long non-coding rna can either have a suppressive function in terms of cancer development, or promote its progression. a good example of transporters that carry lncrnas are exosomes, participating in cell-to-cell communication and thereafter affecting physiological and pathological changes. there are still several challenges that needs to be tackled in order to provide efficient ev-based lncrnas therapeutics for clinical application, but the current state of research offers promise.      \n",
      "['the term transcriptome encompasses the complete set of rna molecules applying to an entire organism or specific cell type, making it more dynamic than the genome. two major classes of regulatory non-coding rnas (ncrnas) which lack any transcriptive capability include micrornas and long non-coding rnass (lncrnas). they play a significant role in diverse cellular processes from enabling normal development to disease progression, as well as cell communication. a valuable example of a biological carrier that can transport abundant quantities of lncrna is that of the exosome: a type of extracellular vesicle involved in cell-to-cell communication and disease transmission. its role has been documented in both physiological conditions and pathological changes such as cancer development, where they are responsible for the regulation of various processes including immunosuppression, proliferation and induction of pre-metastatic niche formation. in this review, the role of a number of exosomal lncrna molecules will be discussed.', 'the first scientific report to examine the possibility that intracellular structures could be associated with the process of budding vesicles bearing receptors during maturation, using ferritin-labelled proteins and anti-igg, recorded the externalization of transferrin receptors into the intercellular space during sheep reticulocyte maturation (1). they belong to the group of membrane-derived vesicles known as extracellular vesicles (evs), together with oncosomes, ectosomes or apoptotic bodies (5). the classification of each vesicle to its specific group depends on genesis, composition, size and density (see table i). extracellular vesicles can be secreted constitutively or as a result of specific induction (6). the origin of exosomes is linked to the creation of multivesicular bodies (mvbs) in the endosomal pathway; mvbs are structures with a lipid bilayer and a density of 1.12–1.19 g/ml (7) and which display 5′ nucleotidase activity (8). exosomes are released from many types of healthy or tumour cells, although more abundantly in the latter (9), and can be found in the tumour microenvironment (tme) and blood samples of cancer patients (10). physiologically, exosomes can be found in urine (10), sperm (3), amniotic fluid (9) and various other biological fluids. the role of exosomes in metastasis, angiogenesis and epithelial-to-mesenchymal transition (emt) has been confirmed in cancer development by various studies (9). exosomes released by tumour cells were shown to constitute a leading source of antigens for dendritic cells inducing antitumour immune responses (11). the physiological functions of exosomes include cellular communication, immunity, infections, elimination of waste products and signalling (12). there is also evidence of their participation in aging-related diseases i.e. neurodegeneration when different types of mrnas, mirnas or lncrna change their abundance inside nanovesicles (13).', 'exosome secretions and their molecular mechanisms are rather obscure, since their release is regulated by several signal molecules and various processes including ceramide synthesis and casignalling (3). proteins that interact with the cell membrane and perform lipid bilayer deformation are epsin, amphiphysin, endofilin, syndapin and dynamin (4). the biogenesis follows the following sequence: the process begins with membrane invagination and exosome release to cytoplasm, followed by early endosome (ee) formation, and then the formation of intraluminal vesicles (ilvs) inside the late endosome (le). under both normal and pathological conditions, exosomes have an endocytic origin and are released by different types of cells. although exosomes typically mimic the composition of the parent cells, they may contain a few signature proteins. following the formation of exosomes within the endocytic pathway, they are released from the plasma membrane via mvbs from early endosome maturation and may further fuse with lysosomes or the plasma membrane. the most common and well-known mechanism of cargo sorting is based on the action of proteins from endosomal sorting complex required for transport (escrt) (6). when this pathway is inactivated, there is a possibility to recruit sumoylated protein hnrnpa2b1 [it binds microrna (14)] or maintain the signal through tetraspanin-enriched microdomains (tems) composed of transmembrane glycoproteins (8,15). the most important proteins associated with escrt are: alix (alg-2-interacting protein x), syndecan and syntenin (16). syntenin ends the formation process through syndecan sorting and binding to alix, which affects escrt-iii (4). direct alix-syntenin interaction is possible through lypx(n)l motifs (16), which are observed in the viral proteins found in late assembly domains (l-domains), these being responsible for recruiting the host escrt machinery directly or via escrt-associated proteins. the final product of this escrt and auxiliary protein activity is the creation of an mvb containing exosomes. despite general syntenin-syndecan-alix axis, there are some other molecular individuals involved in controlling escrt. examples are adp-ribosylation factor 6 (arf6) gtpase and phospholipase d2 (pld2) enzyme which are considered as proteins associated with syntenin (17) and are responsible for the control of the budding of ilvs into mvbs (18). lip5 (lyst-interacting protein 5), also known as vesicle trafficking 1 protein (vta1), is a cofactor for vps4 atpase that enhances vps4-mediated disassembly of escrt-iii polymer (19). cep55 (centrosomal protein 55) can mediate alix and escrt-i complex recruitment; however, interactions with the components of escrt-ii and escrt-iii have also been observed (20). further examples consist of cd2ap (cd2-associated protein), iqgap1 (iq-motif-containing gtpase-activating protein 1) or rock1 (rho-associated kinase 1) which are thought to interact with alix or tsg-101 (tumor susceptibility gene 101). they participate in processes such as cytokinesis (20), viral budding (21) and cell polarity (22), respectively. finally, enzyme heparanase, able to internally cleave heparan sulfate chains on syndecans, acts by increasing exosome production by stimulating intraluminal budding of syndecan and syntenin (23). after the ‘mature’ multivesicular body is formed, it can be transported to lysosomes (degraded hydrolytic enzymes) or interact with the lipid membrane, resulting in exosome release outside the cell. in the latter case, the attachment of mvb to the lipid bilayer takes place with the help of rab-gtp and snare family proteins. following the fusion of mvb and cell membrane, the exosomes can be transported to distant areas of the organism (via blood vessels) or interact with neighbouring cells (4). ‘ targeted’ cells can internalize nanovesicles in endocytic way where the absorption itself is facilitated through phagocytosis, fusion with cell membrane or ligand-receptor interaction. 2 presents the process of biogenesis, secretion and absorption of exosomes by means of escrt machinery. nanovesicle formation exhibits some characteristic stages of biogenesis and involves specific structures present in the cell. the selective mechanism of transporting cargo to the exosome interior is a more heterogenous process, as evidenced by their varied content, even in different types and stages of cancer development (8). the composition of exosomes contains countless types of proteins, including cytokines and growth factors, lipids or nucleic acids (3), including characteristic biomarkers such as cd63, cd81, cd9, tsg-101, alix or hsp70 which allow direct identification of exosomes (6). the profile of the proteins within the vesicles consists of cytoplasmic proteins, cell membrane proteins or proteins from endosomes; however, no proteins from organelles have been detected (6). these proteins include a number of exosomal molecules, such as those connected with mvb biogenesis (e.g., alix, tsg-101) (6), escrt components (3), transport and fusion proteins (annexin, rab-gtp, flotillin) and heat shock cognate (hsc). the tumour exosomes (texs) include additional molecules that participate in the emt process including matrix metalloproteinases (mmps), il-6, tgf-β and immunosupression factors (fasl, trail and gal-9 that stimulates t cell apoptosis) (8). the lipid composition of exosomes is distinct from that of the cell membrane: it is rich in components such as cholesterol, sphingomyelin, glycerophospholipids, phosphatydylinositol, ceramide or phosphatidilserine, as well as prostaglandins and leukotrienes (6). the lipid content in exosomes is higher than that of the parent cell except phosphatidylcholine which is ordinarily decreased (24). an example of exosomal lipid activity is the differentiation of bone-marrow myeloid cells into myeloid-derived suppressor cells (mdscs) by prostaglandin e2. the accumulation of mdscs leads to immunosuppression, which provides favourable conditions for metastasis (8). the participation of lipids in the biogenesis of exosomes is summarized below (table iv). exosomes also can include different types of rna or dna such as mrna, mirna (6), lncrna, dsdna, rna-ror (regulator of reprogramming) (3), and therefore play a vital role in regulating signaling pathways and gene expression (refer to table v). these dna and rna molecules may be transferred into recipient cell by the fusion of exosome and cell membranes, aiding the regulation of large numbers of signaling pathways or expression of genes (3). many studies indicate elevated levels of lncrna in extracellular exosomes compared to parent cells (25,26). this can be attributed to the action of nucleotide patterns that are present in transcripts as cis-acting elements responsible for targeting them into exosomes (27). the purpose of this review is to highlight the significance of lncrna as a pivotal molecule inside exosomes. therefore, it will summarize the role of various exosomal lncrnas, together with their function in carcinogenesis and in other biological processes.', 'nanovesicle formation exhibits some characteristic stages of biogenesis and involves specific structures present in the cell. the selective mechanism of transporting cargo to the exosome interior is a more heterogenous process, as evidenced by their varied content, even in different types and stages of cancer development (8). the composition of exosomes contains countless types of proteins, including cytokines and growth factors, lipids or nucleic acids (3), including characteristic biomarkers such as cd63, cd81, cd9, tsg-101, alix or hsp70 which allow direct identification of exosomes (6). the profile of the proteins within the vesicles consists of cytoplasmic proteins, cell membrane proteins or proteins from endosomes; however, no proteins from organelles have been detected (6). these proteins include a number of exosomal molecules, such as those connected with mvb biogenesis (e.g., alix, tsg-101) (6), escrt components (3), transport and fusion proteins (annexin, rab-gtp, flotillin) and heat shock cognate (hsc). the tumour exosomes (texs) include additional molecules that participate in the emt process including matrix metalloproteinases (mmps), il-6, tgf-β and immunosupression factors (fasl, trail and gal-9 that stimulates t cell apoptosis) (8). the lipid composition of exosomes is distinct from that of the cell membrane: it is rich in components such as cholesterol, sphingomyelin, glycerophospholipids, phosphatydylinositol, ceramide or phosphatidilserine, as well as prostaglandins and leukotrienes (6). the lipid content in exosomes is higher than that of the parent cell except phosphatidylcholine which is ordinarily decreased (24). an example of exosomal lipid activity is the differentiation of bone-marrow myeloid cells into myeloid-derived suppressor cells (mdscs) by prostaglandin e2. the accumulation of mdscs leads to immunosuppression, which provides favourable conditions for metastasis (8). the participation of lipids in the biogenesis of exosomes is summarized below (table iv). exosomes also can include different types of rna or dna such as mrna, mirna (6), lncrna, dsdna, rna-ror (regulator of reprogramming) (3), and therefore play a vital role in regulating signaling pathways and gene expression (refer to table v). these dna and rna molecules may be transferred into recipient cell by the fusion of exosome and cell membranes, aiding the regulation of large numbers of signaling pathways or expression of genes (3). many studies indicate elevated levels of lncrna in extracellular exosomes compared to parent cells (25,26). this can be attributed to the action of nucleotide patterns that are present in transcripts as cis-acting elements responsible for targeting them into exosomes (27). the purpose of this review is to highlight the significance of lncrna as a pivotal molecule inside exosomes. therefore, it will summarize the role of various exosomal lncrnas, together with their function in carcinogenesis and in other biological processes.', 'nanovesicle formation exhibits some characteristic stages of biogenesis and involves specific structures present in the cell. the selective mechanism of transporting cargo to the exosome interior is a more heterogenous process, as evidenced by their varied content, even in different types and stages of cancer development (8). the composition of exosomes contains countless types of proteins, including cytokines and growth factors, lipids or nucleic acids (3), including characteristic biomarkers such as cd63, cd81, cd9, tsg-101, alix or hsp70 which allow direct identification of exosomes (6).', 'the profile of the proteins within the vesicles consists of cytoplasmic proteins, cell membrane proteins or proteins from endosomes; however, no proteins from organelles have been detected (6). these proteins include a number of exosomal molecules, such as those connected with mvb biogenesis (e.g., alix, tsg-101) (6), escrt components (3), transport and fusion proteins (annexin, rab-gtp, flotillin) and heat shock cognate (hsc). the tumour exosomes (texs) include additional molecules that participate in the emt process including matrix metalloproteinases (mmps), il-6, tgf-β and immunosupression factors (fasl, trail and gal-9 that stimulates t cell apoptosis) (8).', 'the lipid composition of exosomes is distinct from that of the cell membrane: it is rich in components such as cholesterol, sphingomyelin, glycerophospholipids, phosphatydylinositol, ceramide or phosphatidilserine, as well as prostaglandins and leukotrienes (6). the lipid content in exosomes is higher than that of the parent cell except phosphatidylcholine which is ordinarily decreased (24). an example of exosomal lipid activity is the differentiation of bone-marrow myeloid cells into myeloid-derived suppressor cells (mdscs) by prostaglandin e2. the accumulation of mdscs leads to immunosuppression, which provides favourable conditions for metastasis (8). the participation of lipids in the biogenesis of exosomes is summarized below (table iv).', 'exosomes also can include different types of rna or dna such as mrna, mirna (6), lncrna, dsdna, rna-ror (regulator of reprogramming) (3), and therefore play a vital role in regulating signaling pathways and gene expression (refer to table v). these dna and rna molecules may be transferred into recipient cell by the fusion of exosome and cell membranes, aiding the regulation of large numbers of signaling pathways or expression of genes (3). many studies indicate elevated levels of lncrna in extracellular exosomes compared to parent cells (25,26). this can be attributed to the action of nucleotide patterns that are present in transcripts as cis-acting elements responsible for targeting them into exosomes (27). the purpose of this review is to highlight the significance of lncrna as a pivotal molecule inside exosomes. therefore, it will summarize the role of various exosomal lncrnas, together with their function in carcinogenesis and in other biological processes.', 'the functional annotation of 60,770 full length longer cdnas and rare transcripts in the mouse transcriptome resulted in the discovery of a novel class of non-coding cdnas, among which ~80% of the transcripts are not spliced (28). the lncrnas constitute a class of transcripts that does not encode proteins and whose length exceeds 200 bp (29). this group includes several heterogenous molecules that are difficult to categorize: lncrnas can be divided into long intergenic non-coding rnas (lincrnas), long intronic non-coding rnas and half-stau1-binding site rnas (1/2sbsrnas) (30). depending on the dna coding strand, the lncrnas can be classified as sense or antisense transcripts (31). some resemblance can be found between mrnas and lncrnas in some biochemical processes, for example mechanisms of polyadenylation and splicing or participation of rna polymerase ii in the process of their transcription (32). the roles of these molecules are connected with transduction signal, decoys, guides or scaffolds (31); however, their main function is associated with their action as transcription regulators of protein-coding genes (32). there is also the probability that lncrnas act like a ‘sponge’-leading to mirna recruitment into evs, or possibly to provide the mechanisms required for microrna loading (13). these findings confirm both the diversity of lncrnas and their participation in carcinogenesis by demonstrating their influence on the promotion of angiogenesis, protein stability or mirna inhibition by acting as a sponge. in addition, as lncrnas are detected in texs or apoptotic bodies, and have high stability during circulation, they could be considered as potential cancer biomarkers (33); however, some studies indicate they may display tumour suppression behavior through the blocking of the transcription of apoptosis-inhibiting genes and stimulation of p53 expression (34) or the structural modification of chromatin (35). a classic feature of the tumour microenvironment is hypoxia, which has a notable impact on cancer progression. activation of its pathway via the transcription factor hypoxia inducible factor (hif) plays a part in metastasis and a more aggressive phenotype. the role of lncrnas in hypoxia-driven cancer progression came into view recently, where these hypoxia-responsive lncrnas play a critical part in regulating hypoxic gene expressions (36). hotair: hox transcript antisense rna has been associated with progression and poor prognosis in patients with squamous cell carcinoma (scc), hepatocellular carcinoma (hcc), urothelial bladder cancer (ubc) or colorectal cancer (crc) (37). yan et al (38) report the involvement of hotair in the repression of wif-1-a protein implicated in the wnt signaling pathway. moreover, epigenetic regulation is also achievable: it participates in the migration, invasion or proliferation, potentiating through silencing of mir-205 in bladder cancer. in addition, ubc cells displayed increased invasion with migration corresponding to regulation of the emt pathway, which was confirmed by knockdown of hotair. this resulted in reduced invasiveness by influencing genes connected with emt such as mmp1 (matrix metalloproteinase-1), zeb1 (zinc finger e-box-binding homeobox 1), twist1 (twist-related protein 1), snai1 (snail family zinc finger 1), zo-1 (zonula occludens 1), lamc2 (laminin, gamma 2), lamb3 (laminin, beta 3) or abl2 (abl proto-oncogene 2) (37). studies by xie et al, have shown that salivary hotair could be used as biomarker in diagnostics: it had good discriminatory power for differentiating pancreatic cancer from healthy patients and benign pancreatic tumour (39, 40). in addition to its contribution in cancerous diseases, hotair has also been described to play a role in rheumatoid arthritis, where its transcript activates mmp-2 and mmp-13 in synoviocytes and osteoclasts. furthermore, hotair-loaded exosomes with enriched lncrna activate macrophages and influence immune response (41). malat-1: metastasis-associated lung adenocarcinoma transcript 1 or nuclear-enriched abundant transcript 2 (neat-2) was the first lncrna to be associated with metastasis in non-small cell lung cancer (nsclc). this transcript, similar to the hotair lncrna, is also connected with migration or tumour growth induction. zhang et al (42), indicated increased expression of transcript compared to healthy controls, and an association with higher tnm stage in patients with cancer. in vitro study knockdown of malat-1 in cancer cell lines significantly inhibited cell proliferation and colony formation, although it also induced cell cycle arrest and cell apoptosis due to a decrease in s phase progression. in addition, cyclin d1 and cyclin d2 downregulation was also observed, suggesting that malat-1 was involved in acceleration of the cell cycle. this indicates that malat-1 can be an important therapeutic target when developing treatments for nsclc patients, because of its participation in the malignant phenotype of cancer through gene expression regulation (43). alongside nsclc, malat-1 has been proposed as a mediator of angiogenesis in thyroid cancer. huang et al (44), found it to play a role in the secretion of the fibroblast growth factor 2 (fgf) protein from tumour-associated macrophages (tams), which led to vascularization, promotion of proliferation, invasion and migration of cancer cells. nonetheless, malat-1 participation in releasing inflammatory cytokines or fgf2 secretion was predominantly blocked by overexpression of fgf2. zfas1: initial studies concerning the zinc finger antisense 1 (zfas1) lncrna refer to alveolar development in the mammary gland, with a proposed role in the regulation of alveolar development and epithelial cell differentiation in the mammary gland (45). the transcript has been found to promote cancer progression by cell cycle regulation through cyclin-dependent kinase 1 (cdk1) interaction or destabilization of the p53 protein. the level of zfas1 was also upregulated in exosomes from hcc, crc and gastric cancer (gc). pan et al (46), noticed that overexpression of this transcript leads to proliferation and migration of gc cells and zfas1-positive exosomes which can be internalized by mkn-28 cells. knockdown of zfas1 inhibited the migration, proliferation and emt process; however, it also induced cell cycle arrest and programmed cell death, serving as a potential tumour suppressor. these findings have been attributed to decreased erk, bcl-2 and increased bax protein levels. additionally, zfas1 knockdown was observed to suppress cell migration by decreasing the expression of emt transcription factors such as slug or twist. these findings suggest that zfas1 could promote metastasis by cell cycle acceleration or support emt playing a pivotal role in gc diagnosis (47). h19: h19 lncrna is also involved in tumor metastasis and has been described as a master factor in cancer biology due to its frequent deregulation in almost all tumours, both in the initiation and progression steps (48). h19 is connected with the downregulation of e-cadherin, which influences cell adhesion and leads to spread of cancer cells. in addition, conigliaro et al (49) investigated h19 as a pro-angiogenic molecule promoting cell-to-cell adhesion (cd90+ cells with endothelial cell monolayer) and association with increased expression of vegf and icam1 transcripts which in turn leads to new vessel development. h19 may also act as an epigenetic modulator or as mirna sponge (50). in conclusion, this type of lncrna could have a range of impacts on target cells and some of its functions still remain unknown; nevertheless, h19 has been proposed as a potential therapeutic target (e.g., in hcc) (51). pou3f3: in vitro studies indicate that this transcript increases viability and cell proliferation in gliomas and its overexpression is associated with tumour grading (52). hu et al (53) investigated whether exosomal pou3f3 from glioma cells could promote angiogenesis and its effect on endothelial cells. they indicate that lncrna enriched the exosomes regulating the migration, proliferation and angiogenesis of human brain microvascular endothelial cells (hbmecs) in both in vitro and in vivo studies. silencing pou3f3 using shrna decreased the migratory ability of endothelial cells but did not affect their motility. pou3f3 overexpression in hbmecs caused by lncrna enriched exosome internalization, and significantly upregulated the transcript level of bfgf, bfgfr, angio and vegfa. these findings indicate that pou3f3 lncrna can be an essential molecule in cell-to-cell communication or a regulator of angiogenesis in glioma cells (53). uces are 100% maintained genomic sequences that are greater than 200 bases in length and are conserved across human, mouse and rat genomes (54). the localization of these elements is connected with fragile sites and cancer-associated regions of the genome. a study on the role of exosomal ultraconserved lncrna in modulating target cell phenotype as a result of genomic changes found that tuc339 upregulation in hcc cell lines resulted in an enhancement of cell growth and a reduction of adhesion to cell-extracellular matrix (ecm). the knockdown of tuc339 decreased proliferation and altered the expression of a total of 843 genes, 469 of which were inhibited (56). ror: lncrna ror participates in liver cancer through disruption in tgf-β pathway. although tgf-β has been related to cancer chemoresistance, the molecular actions involved in this event remain unknown. takahashi et al (57), identified a possibly mechanism by which lncrna may mediate chemoresistance dependent on tgf-β. they indicate that tgf-β reduced the sensitivity of hcc cells to sorafenib or doxorubicin, with a further reduction of sorafenib-dependent caspase 3/7 activity, leading to inhibition of the apoptosis process. moreover, the release of extracellular vesicles and packaging of lncrna within vesicles were also modulated by tgf-β. one of the selectively enriched exosomal lncrnas thought to be a potential mediator of chemoresistance is rna-ror. using a molecular pathway connected with p53 dependent signaling, lincrna can contribute to tumor development by inhibiting apoptosis through the repression of p53. additionally, knockdown of this lncrna results in increased expression of caspase 8 and gadd45b, leading to apoptosis induction and growth arrest. these data suggest that lincrna ror can be an important mediator in cell-to-cell communication and its contribution in chemoresistance has been confirmed in research. inhibition of this transcript resulted in reversion of drug resistance, leading to cell death (58). vldlr: one of the long-intergenic non-coding rna transcripts that support hcc development is called vldlr (59). by showing that knockdown of this rna can result in cell cycle arrest in g1/s phase, takahashi et al (60), confirmed that it regulates hcc cell proliferation. moreover, the quantity of lncrna was increased in both hcc cells and extracellular vesicles following chemotherapeutic stress caused by sorafenib, doxorubicin and camptothecin, thus enhancing cell viability. furthermore, the extracellular transfer of vldlr to adjacent tumour cells could participate in chemoresistance through the modulation of abcg2 gene expression. the summary of the other lncrna molecules that participate in tumour development is presented in table vi. in contrast to the lncrnas with pro-cancerous properties, there is also another group of transcripts that could support normal cells rather than stimulating their conversion into a neoplastic phenotype (61). gas5: several studies have implied that the growth arrest specific 5 gene molecule has not been connected with cancer progression, as its expression has been observed to be reduced in various cancer types (62,63). pickard et al (64), noticed that gas5 participates in apoptosis regulation in prostate cancer cells. they indicated that the high expression of gas5 level reduces tumour cell survival and hence induces pro-apoptotic activity. on the other hand, when gas5 was downregulated, programmed cell death was diminished but growth arrest was not. in prostate carcinoma gas5 has been found to bind to the receptor domain and inhibit transcriptional stimulation, leading to increased death of tumour cells (65). particl: some studies also confirmed the role of lncrnas in the methylation process in response to radiation. one of this lncrna is particl (promoter of mat2a antisense radiation-induced circulating long non-coding rna) a trans-acting mediator of dna, and histone lysine methylation, a clever component for gene silencing (66). the findings indicate that in low dose irradiation, particl can enhance ezh2 (enhancer of zeste homolog 2) expression, which in turn catalyzes the addition of methyl groups to histone h3 at lysine 27. moreover, there was also an observed increase in the activity of the dnmt1 enzyme (dna methyltransferase 1), global methylome enhancement methylome regulation e.g., cpg island methylation of wwox gene. finally, speculation about particl as an epigenetic modifying platform targeting chromatin structure modulation through recruitment of prc2 (polycomb repressive complex 2) has been proposed; this has been proposed to act by the binding of lncrna to a subunit of prc2 called suz12 (suppressor of zeste 12). these data indicate that particl interlinks regulators of epigenetic modifications that may affect the suppression of transcription (67). ccnd1: another lncrna found in exosomes (68) and connected with ionizing radiation-dependent transcription (69) is ncrna ccnd1 (cyclin d1). this single strand transcript binds to the tls (translocated in liposarcoma) modulator, thus recruiting it to ccnd1 promoter and inducing negative regulation of gene transcription. in addition, it also blocks the activity of creb (camp response element binding) and p300 proteins. exo1-4: the four molecules that occur abundantly in exosomes in cervical cancer were defined as exo1-4 (70). those transcripts contain dnase hypersensitive regions as well as rnapii and ctcf binding sites (71). exo1-4 is a subset of lncrnas that modulate cell function through increasing recipient cell viability by binding to various proteins: for example, exo2 directly interacts with lactate dehydrogenase b (ldhb) while exo4 reacts with high mobility group protein 17 (hmg-17). this speculates that lncrna exo1-4 has an impact on processes like cell metabolism or nucleosomal architecture. because lncrna has greater tissue specificity than mrna (72), these molecules may act as specific diagnostic biomarkers (73). when included in extracellular vesicles, circulation of rna in body fluids is stable and able to resist the activity of ribonucleases (74), which makes them potential cancer prognostic markers (75). the profiles of lncrna varies depending on tumour types that may be useful for clinical research, and moreover, these molecules could replace biopsies owing to the reduced level of invasiveness (76). exosomal lncrna can be nominated as cancer biomarkers but some of them are responsible for the development of other diseases (77). a set of differently expressed lncrna associated with non-cancerous or cancerous diseases is shown in table vii.', 'a classic feature of the tumour microenvironment is hypoxia, which has a notable impact on cancer progression. activation of its pathway via the transcription factor hypoxia inducible factor (hif) plays a part in metastasis and a more aggressive phenotype. the role of lncrnas in hypoxia-driven cancer progression came into view recently, where these hypoxia-responsive lncrnas play a critical part in regulating hypoxic gene expressions (36). hotair: hox transcript antisense rna has been associated with progression and poor prognosis in patients with squamous cell carcinoma (scc), hepatocellular carcinoma (hcc), urothelial bladder cancer (ubc) or colorectal cancer (crc) (37). yan et al (38) report the involvement of hotair in the repression of wif-1-a protein implicated in the wnt signaling pathway. moreover, epigenetic regulation is also achievable: it participates in the migration, invasion or proliferation, potentiating through silencing of mir-205 in bladder cancer. in addition, ubc cells displayed increased invasion with migration corresponding to regulation of the emt pathway, which was confirmed by knockdown of hotair. this resulted in reduced invasiveness by influencing genes connected with emt such as mmp1 (matrix metalloproteinase-1), zeb1 (zinc finger e-box-binding homeobox 1), twist1 (twist-related protein 1), snai1 (snail family zinc finger 1), zo-1 (zonula occludens 1), lamc2 (laminin, gamma 2), lamb3 (laminin, beta 3) or abl2 (abl proto-oncogene 2) (37). studies by xie et al, have shown that salivary hotair could be used as biomarker in diagnostics: it had good discriminatory power for differentiating pancreatic cancer from healthy patients and benign pancreatic tumour (39, 40). in addition to its contribution in cancerous diseases, hotair has also been described to play a role in rheumatoid arthritis, where its transcript activates mmp-2 and mmp-13 in synoviocytes and osteoclasts. furthermore, hotair-loaded exosomes with enriched lncrna activate macrophages and influence immune response (41). malat-1: metastasis-associated lung adenocarcinoma transcript 1 or nuclear-enriched abundant transcript 2 (neat-2) was the first lncrna to be associated with metastasis in non-small cell lung cancer (nsclc). this transcript, similar to the hotair lncrna, is also connected with migration or tumour growth induction. zhang et al (42), indicated increased expression of transcript compared to healthy controls, and an association with higher tnm stage in patients with cancer. in vitro study knockdown of malat-1 in cancer cell lines significantly inhibited cell proliferation and colony formation, although it also induced cell cycle arrest and cell apoptosis due to a decrease in s phase progression. in addition, cyclin d1 and cyclin d2 downregulation was also observed, suggesting that malat-1 was involved in acceleration of the cell cycle. this indicates that malat-1 can be an important therapeutic target when developing treatments for nsclc patients, because of its participation in the malignant phenotype of cancer through gene expression regulation (43). alongside nsclc, malat-1 has been proposed as a mediator of angiogenesis in thyroid cancer. huang et al (44), found it to play a role in the secretion of the fibroblast growth factor 2 (fgf) protein from tumour-associated macrophages (tams), which led to vascularization, promotion of proliferation, invasion and migration of cancer cells. nonetheless, malat-1 participation in releasing inflammatory cytokines or fgf2 secretion was predominantly blocked by overexpression of fgf2. zfas1: initial studies concerning the zinc finger antisense 1 (zfas1) lncrna refer to alveolar development in the mammary gland, with a proposed role in the regulation of alveolar development and epithelial cell differentiation in the mammary gland (45). the transcript has been found to promote cancer progression by cell cycle regulation through cyclin-dependent kinase 1 (cdk1) interaction or destabilization of the p53 protein. the level of zfas1 was also upregulated in exosomes from hcc, crc and gastric cancer (gc). pan et al (46), noticed that overexpression of this transcript leads to proliferation and migration of gc cells and zfas1-positive exosomes which can be internalized by mkn-28 cells. knockdown of zfas1 inhibited the migration, proliferation and emt process; however, it also induced cell cycle arrest and programmed cell death, serving as a potential tumour suppressor. these findings have been attributed to decreased erk, bcl-2 and increased bax protein levels. additionally, zfas1 knockdown was observed to suppress cell migration by decreasing the expression of emt transcription factors such as slug or twist. these findings suggest that zfas1 could promote metastasis by cell cycle acceleration or support emt playing a pivotal role in gc diagnosis (47). h19: h19 lncrna is also involved in tumor metastasis and has been described as a master factor in cancer biology due to its frequent deregulation in almost all tumours, both in the initiation and progression steps (48). h19 is connected with the downregulation of e-cadherin, which influences cell adhesion and leads to spread of cancer cells. in addition, conigliaro et al (49) investigated h19 as a pro-angiogenic molecule promoting cell-to-cell adhesion (cd90+ cells with endothelial cell monolayer) and association with increased expression of vegf and icam1 transcripts which in turn leads to new vessel development. h19 may also act as an epigenetic modulator or as mirna sponge (50). in conclusion, this type of lncrna could have a range of impacts on target cells and some of its functions still remain unknown; nevertheless, h19 has been proposed as a potential therapeutic target (e.g., in hcc) (51). pou3f3: in vitro studies indicate that this transcript increases viability and cell proliferation in gliomas and its overexpression is associated with tumour grading (52). hu et al (53) investigated whether exosomal pou3f3 from glioma cells could promote angiogenesis and its effect on endothelial cells. they indicate that lncrna enriched the exosomes regulating the migration, proliferation and angiogenesis of human brain microvascular endothelial cells (hbmecs) in both in vitro and in vivo studies. silencing pou3f3 using shrna decreased the migratory ability of endothelial cells but did not affect their motility. pou3f3 overexpression in hbmecs caused by lncrna enriched exosome internalization, and significantly upregulated the transcript level of bfgf, bfgfr, angio and vegfa. these findings indicate that pou3f3 lncrna can be an essential molecule in cell-to-cell communication or a regulator of angiogenesis in glioma cells (53). uces are 100% maintained genomic sequences that are greater than 200 bases in length and are conserved across human, mouse and rat genomes (54). the localization of these elements is connected with fragile sites and cancer-associated regions of the genome. a study on the role of exosomal ultraconserved lncrna in modulating target cell phenotype as a result of genomic changes found that tuc339 upregulation in hcc cell lines resulted in an enhancement of cell growth and a reduction of adhesion to cell-extracellular matrix (ecm). the knockdown of tuc339 decreased proliferation and altered the expression of a total of 843 genes, 469 of which were inhibited (56). ror: lncrna ror participates in liver cancer through disruption in tgf-β pathway. although tgf-β has been related to cancer chemoresistance, the molecular actions involved in this event remain unknown. takahashi et al (57), identified a possibly mechanism by which lncrna may mediate chemoresistance dependent on tgf-β. they indicate that tgf-β reduced the sensitivity of hcc cells to sorafenib or doxorubicin, with a further reduction of sorafenib-dependent caspase 3/7 activity, leading to inhibition of the apoptosis process. moreover, the release of extracellular vesicles and packaging of lncrna within vesicles were also modulated by tgf-β. one of the selectively enriched exosomal lncrnas thought to be a potential mediator of chemoresistance is rna-ror. using a molecular pathway connected with p53 dependent signaling, lincrna can contribute to tumor development by inhibiting apoptosis through the repression of p53. additionally, knockdown of this lncrna results in increased expression of caspase 8 and gadd45b, leading to apoptosis induction and growth arrest. these data suggest that lincrna ror can be an important mediator in cell-to-cell communication and its contribution in chemoresistance has been confirmed in research. inhibition of this transcript resulted in reversion of drug resistance, leading to cell death (58). vldlr: one of the long-intergenic non-coding rna transcripts that support hcc development is called vldlr (59). by showing that knockdown of this rna can result in cell cycle arrest in g1/s phase, takahashi et al (60), confirmed that it regulates hcc cell proliferation. moreover, the quantity of lncrna was increased in both hcc cells and extracellular vesicles following chemotherapeutic stress caused by sorafenib, doxorubicin and camptothecin, thus enhancing cell viability. furthermore, the extracellular transfer of vldlr to adjacent tumour cells could participate in chemoresistance through the modulation of abcg2 gene expression. the summary of the other lncrna molecules that participate in tumour development is presented in table vi. in contrast to the lncrnas with pro-cancerous properties, there is also another group of transcripts that could support normal cells rather than stimulating their conversion into a neoplastic phenotype (61). gas5: several studies have implied that the growth arrest specific 5 gene molecule has not been connected with cancer progression, as its expression has been observed to be reduced in various cancer types (62,63). pickard et al (64), noticed that gas5 participates in apoptosis regulation in prostate cancer cells. they indicated that the high expression of gas5 level reduces tumour cell survival and hence induces pro-apoptotic activity. on the other hand, when gas5 was downregulated, programmed cell death was diminished but growth arrest was not. in prostate carcinoma gas5 has been found to bind to the receptor domain and inhibit transcriptional stimulation, leading to increased death of tumour cells (65). particl: some studies also confirmed the role of lncrnas in the methylation process in response to radiation. one of this lncrna is particl (promoter of mat2a antisense radiation-induced circulating long non-coding rna) a trans-acting mediator of dna, and histone lysine methylation, a clever component for gene silencing (66). the findings indicate that in low dose irradiation, particl can enhance ezh2 (enhancer of zeste homolog 2) expression, which in turn catalyzes the addition of methyl groups to histone h3 at lysine 27. moreover, there was also an observed increase in the activity of the dnmt1 enzyme (dna methyltransferase 1), global methylome enhancement methylome regulation e.g., cpg island methylation of wwox gene. finally, speculation about particl as an epigenetic modifying platform targeting chromatin structure modulation through recruitment of prc2 (polycomb repressive complex 2) has been proposed; this has been proposed to act by the binding of lncrna to a subunit of prc2 called suz12 (suppressor of zeste 12). these data indicate that particl interlinks regulators of epigenetic modifications that may affect the suppression of transcription (67). ccnd1: another lncrna found in exosomes (68) and connected with ionizing radiation-dependent transcription (69) is ncrna ccnd1 (cyclin d1). this single strand transcript binds to the tls (translocated in liposarcoma) modulator, thus recruiting it to ccnd1 promoter and inducing negative regulation of gene transcription. in addition, it also blocks the activity of creb (camp response element binding) and p300 proteins. exo1-4: the four molecules that occur abundantly in exosomes in cervical cancer were defined as exo1-4 (70). those transcripts contain dnase hypersensitive regions as well as rnapii and ctcf binding sites (71). exo1-4 is a subset of lncrnas that modulate cell function through increasing recipient cell viability by binding to various proteins: for example, exo2 directly interacts with lactate dehydrogenase b (ldhb) while exo4 reacts with high mobility group protein 17 (hmg-17). this speculates that lncrna exo1-4 has an impact on processes like cell metabolism or nucleosomal architecture. because lncrna has greater tissue specificity than mrna (72), these molecules may act as specific diagnostic biomarkers (73). when included in extracellular vesicles, circulation of rna in body fluids is stable and able to resist the activity of ribonucleases (74), which makes them potential cancer prognostic markers (75). the profiles of lncrna varies depending on tumour types that may be useful for clinical research, and moreover, these molecules could replace biopsies owing to the reduced level of invasiveness (76). exosomal lncrna can be nominated as cancer biomarkers but some of them are responsible for the development of other diseases (77). a set of differently expressed lncrna associated with non-cancerous or cancerous diseases is shown in table vii.', 'a classic feature of the tumour microenvironment is hypoxia, which has a notable impact on cancer progression. activation of its pathway via the transcription factor hypoxia inducible factor (hif) plays a part in metastasis and a more aggressive phenotype. the role of lncrnas in hypoxia-driven cancer progression came into view recently, where these hypoxia-responsive lncrnas play a critical part in regulating hypoxic gene expressions (36). hotair: hox transcript antisense rna has been associated with progression and poor prognosis in patients with squamous cell carcinoma (scc), hepatocellular carcinoma (hcc), urothelial bladder cancer (ubc) or colorectal cancer (crc) (37). yan et al (38) report the involvement of hotair in the repression of wif-1-a protein implicated in the wnt signaling pathway. moreover, epigenetic regulation is also achievable: it participates in the migration, invasion or proliferation, potentiating through silencing of mir-205 in bladder cancer. in addition, ubc cells displayed increased invasion with migration corresponding to regulation of the emt pathway, which was confirmed by knockdown of hotair. this resulted in reduced invasiveness by influencing genes connected with emt such as mmp1 (matrix metalloproteinase-1), zeb1 (zinc finger e-box-binding homeobox 1), twist1 (twist-related protein 1), snai1 (snail family zinc finger 1), zo-1 (zonula occludens 1), lamc2 (laminin, gamma 2), lamb3 (laminin, beta 3) or abl2 (abl proto-oncogene 2) (37). studies by xie et al, have shown that salivary hotair could be used as biomarker in diagnostics: it had good discriminatory power for differentiating pancreatic cancer from healthy patients and benign pancreatic tumour (39, 40). in addition to its contribution in cancerous diseases, hotair has also been described to play a role in rheumatoid arthritis, where its transcript activates mmp-2 and mmp-13 in synoviocytes and osteoclasts. furthermore, hotair-loaded exosomes with enriched lncrna activate macrophages and influence immune response (41). malat-1: metastasis-associated lung adenocarcinoma transcript 1 or nuclear-enriched abundant transcript 2 (neat-2) was the first lncrna to be associated with metastasis in non-small cell lung cancer (nsclc). this transcript, similar to the hotair lncrna, is also connected with migration or tumour growth induction. zhang et al (42), indicated increased expression of transcript compared to healthy controls, and an association with higher tnm stage in patients with cancer. in vitro study knockdown of malat-1 in cancer cell lines significantly inhibited cell proliferation and colony formation, although it also induced cell cycle arrest and cell apoptosis due to a decrease in s phase progression. in addition, cyclin d1 and cyclin d2 downregulation was also observed, suggesting that malat-1 was involved in acceleration of the cell cycle. this indicates that malat-1 can be an important therapeutic target when developing treatments for nsclc patients, because of its participation in the malignant phenotype of cancer through gene expression regulation (43). alongside nsclc, malat-1 has been proposed as a mediator of angiogenesis in thyroid cancer. huang et al (44), found it to play a role in the secretion of the fibroblast growth factor 2 (fgf) protein from tumour-associated macrophages (tams), which led to vascularization, promotion of proliferation, invasion and migration of cancer cells. nonetheless, malat-1 participation in releasing inflammatory cytokines or fgf2 secretion was predominantly blocked by overexpression of fgf2. zfas1: initial studies concerning the zinc finger antisense 1 (zfas1) lncrna refer to alveolar development in the mammary gland, with a proposed role in the regulation of alveolar development and epithelial cell differentiation in the mammary gland (45). the transcript has been found to promote cancer progression by cell cycle regulation through cyclin-dependent kinase 1 (cdk1) interaction or destabilization of the p53 protein. the level of zfas1 was also upregulated in exosomes from hcc, crc and gastric cancer (gc). pan et al (46), noticed that overexpression of this transcript leads to proliferation and migration of gc cells and zfas1-positive exosomes which can be internalized by mkn-28 cells. knockdown of zfas1 inhibited the migration, proliferation and emt process; however, it also induced cell cycle arrest and programmed cell death, serving as a potential tumour suppressor. these findings have been attributed to decreased erk, bcl-2 and increased bax protein levels. additionally, zfas1 knockdown was observed to suppress cell migration by decreasing the expression of emt transcription factors such as slug or twist. these findings suggest that zfas1 could promote metastasis by cell cycle acceleration or support emt playing a pivotal role in gc diagnosis (47). h19: h19 lncrna is also involved in tumor metastasis and has been described as a master factor in cancer biology due to its frequent deregulation in almost all tumours, both in the initiation and progression steps (48). h19 is connected with the downregulation of e-cadherin, which influences cell adhesion and leads to spread of cancer cells. in addition, conigliaro et al (49) investigated h19 as a pro-angiogenic molecule promoting cell-to-cell adhesion (cd90+ cells with endothelial cell monolayer) and association with increased expression of vegf and icam1 transcripts which in turn leads to new vessel development. h19 may also act as an epigenetic modulator or as mirna sponge (50). in conclusion, this type of lncrna could have a range of impacts on target cells and some of its functions still remain unknown; nevertheless, h19 has been proposed as a potential therapeutic target (e.g., in hcc) (51). pou3f3: in vitro studies indicate that this transcript increases viability and cell proliferation in gliomas and its overexpression is associated with tumour grading (52). hu et al (53) investigated whether exosomal pou3f3 from glioma cells could promote angiogenesis and its effect on endothelial cells. they indicate that lncrna enriched the exosomes regulating the migration, proliferation and angiogenesis of human brain microvascular endothelial cells (hbmecs) in both in vitro and in vivo studies. silencing pou3f3 using shrna decreased the migratory ability of endothelial cells but did not affect their motility. pou3f3 overexpression in hbmecs caused by lncrna enriched exosome internalization, and significantly upregulated the transcript level of bfgf, bfgfr, angio and vegfa. these findings indicate that pou3f3 lncrna can be an essential molecule in cell-to-cell communication or a regulator of angiogenesis in glioma cells (53). uces are 100% maintained genomic sequences that are greater than 200 bases in length and are conserved across human, mouse and rat genomes (54). the localization of these elements is connected with fragile sites and cancer-associated regions of the genome. a study on the role of exosomal ultraconserved lncrna in modulating target cell phenotype as a result of genomic changes found that tuc339 upregulation in hcc cell lines resulted in an enhancement of cell growth and a reduction of adhesion to cell-extracellular matrix (ecm). the knockdown of tuc339 decreased proliferation and altered the expression of a total of 843 genes, 469 of which were inhibited (56). ror: lncrna ror participates in liver cancer through disruption in tgf-β pathway. although tgf-β has been related to cancer chemoresistance, the molecular actions involved in this event remain unknown. takahashi et al (57), identified a possibly mechanism by which lncrna may mediate chemoresistance dependent on tgf-β. they indicate that tgf-β reduced the sensitivity of hcc cells to sorafenib or doxorubicin, with a further reduction of sorafenib-dependent caspase 3/7 activity, leading to inhibition of the apoptosis process. moreover, the release of extracellular vesicles and packaging of lncrna within vesicles were also modulated by tgf-β. one of the selectively enriched exosomal lncrnas thought to be a potential mediator of chemoresistance is rna-ror. using a molecular pathway connected with p53 dependent signaling, lincrna can contribute to tumor development by inhibiting apoptosis through the repression of p53. additionally, knockdown of this lncrna results in increased expression of caspase 8 and gadd45b, leading to apoptosis induction and growth arrest. these data suggest that lincrna ror can be an important mediator in cell-to-cell communication and its contribution in chemoresistance has been confirmed in research. inhibition of this transcript resulted in reversion of drug resistance, leading to cell death (58). vldlr: one of the long-intergenic non-coding rna transcripts that support hcc development is called vldlr (59). by showing that knockdown of this rna can result in cell cycle arrest in g1/s phase, takahashi et al (60), confirmed that it regulates hcc cell proliferation. moreover, the quantity of lncrna was increased in both hcc cells and extracellular vesicles following chemotherapeutic stress caused by sorafenib, doxorubicin and camptothecin, thus enhancing cell viability. furthermore, the extracellular transfer of vldlr to adjacent tumour cells could participate in chemoresistance through the modulation of abcg2 gene expression. the summary of the other lncrna molecules that participate in tumour development is presented in table vi.', 'in contrast to the lncrnas with pro-cancerous properties, there is also another group of transcripts that could support normal cells rather than stimulating their conversion into a neoplastic phenotype (61). gas5: several studies have implied that the growth arrest specific 5 gene molecule has not been connected with cancer progression, as its expression has been observed to be reduced in various cancer types (62,63). pickard et al (64), noticed that gas5 participates in apoptosis regulation in prostate cancer cells. they indicated that the high expression of gas5 level reduces tumour cell survival and hence induces pro-apoptotic activity. on the other hand, when gas5 was downregulated, programmed cell death was diminished but growth arrest was not. in prostate carcinoma gas5 has been found to bind to the receptor domain and inhibit transcriptional stimulation, leading to increased death of tumour cells (65). particl: some studies also confirmed the role of lncrnas in the methylation process in response to radiation. one of this lncrna is particl (promoter of mat2a antisense radiation-induced circulating long non-coding rna) a trans-acting mediator of dna, and histone lysine methylation, a clever component for gene silencing (66). the findings indicate that in low dose irradiation, particl can enhance ezh2 (enhancer of zeste homolog 2) expression, which in turn catalyzes the addition of methyl groups to histone h3 at lysine 27. moreover, there was also an observed increase in the activity of the dnmt1 enzyme (dna methyltransferase 1), global methylome enhancement methylome regulation e.g., cpg island methylation of wwox gene. finally, speculation about particl as an epigenetic modifying platform targeting chromatin structure modulation through recruitment of prc2 (polycomb repressive complex 2) has been proposed; this has been proposed to act by the binding of lncrna to a subunit of prc2 called suz12 (suppressor of zeste 12). these data indicate that particl interlinks regulators of epigenetic modifications that may affect the suppression of transcription (67). ccnd1: another lncrna found in exosomes (68) and connected with ionizing radiation-dependent transcription (69) is ncrna ccnd1 (cyclin d1). this single strand transcript binds to the tls (translocated in liposarcoma) modulator, thus recruiting it to ccnd1 promoter and inducing negative regulation of gene transcription. in addition, it also blocks the activity of creb (camp response element binding) and p300 proteins. exo1-4: the four molecules that occur abundantly in exosomes in cervical cancer were defined as exo1-4 (70). those transcripts contain dnase hypersensitive regions as well as rnapii and ctcf binding sites (71). exo1-4 is a subset of lncrnas that modulate cell function through increasing recipient cell viability by binding to various proteins: for example, exo2 directly interacts with lactate dehydrogenase b (ldhb) while exo4 reacts with high mobility group protein 17 (hmg-17). this speculates that lncrna exo1-4 has an impact on processes like cell metabolism or nucleosomal architecture.', 'because lncrna has greater tissue specificity than mrna (72), these molecules may act as specific diagnostic biomarkers (73). when included in extracellular vesicles, circulation of rna in body fluids is stable and able to resist the activity of ribonucleases (74), which makes them potential cancer prognostic markers (75). the profiles of lncrna varies depending on tumour types that may be useful for clinical research, and moreover, these molecules could replace biopsies owing to the reduced level of invasiveness (76). exosomal lncrna can be nominated as cancer biomarkers but some of them are responsible for the development of other diseases (77). a set of differently expressed lncrna associated with non-cancerous or cancerous diseases is shown in table vii.', 'as a result of maintaining full stability of lncrna in extracellular vesicles as mentioned earlier, these transcripts can be taken up by target cells with their full functionality preserved (78). this make evs effective nanocarriers that are capable of regulating lncrnas expression in cancer cells (79). an attractive potential tumour therapy that requires further development maintaining high levels of tumour suppressor lncrnas or destabilizing oncogenic ones (80). h19 is an example of the use of pro-tumorigenic long non-coding transcripts in the specific targeting of tumour cells. the regulatory sequence of this lncrna was used in the successful formation of the bc-819 plasmid. in vivo this construct encodes the toxin diphtheria toxin a (dta) which provided encouraging results in the treatment of bladder or colon cancer, as well as pancreas carcinoma or nsclc (81). there are also potential approaches to inducing overexpression of lncrna meg3 (maternally expressed gene 3) in lung adenocarcinoma in order to increase sensitivity to cisplatin-based chemotherapy (82). another potential type of lncrna-based therapy exploits the ‘sponge’ activity of those transcripts, resulting in lowered mirna activity in tumours (81). even following the identification of numerous lncrnas connected with various diseases, there is still the need to identify more transcripts and clarify their mechanism of action. unbiased genetic screening, lncrna expression patterns and characterization of associated proteins should provide guidance. moreover, the development of better technologies directed to improve lncrna-based therapies will effectively expand their usage as therapeutic or diagnostic strategies. finally, investigation of new tools using the epigenetic functionality of lncrnas could help in the research and treatment of diseases that depend on epigenetics (83). when it comes to the development of exosomal lncrna-based therapeutics, a few problems were identified including uncertain functionality in biological pathways, the pharmacokinetics and toxicity of lncrnas and the precise quantification of ev-bounded non-coding transcripts which need to be addressed accordingly (84). in conclusion, progressive studies of lncrna properties can lead to their use as cancer biomarkers with high sensitivity and accuracy, resulting in early-stage detection, and improved performance of existing clinical biomarkers. long non-coding rna can either have a suppressive function in terms of cancer development, or promote its progression. a good example of transporters that carry lncrnas are exosomes, participating in cell-to-cell communication and thereafter affecting physiological and pathological changes. there are still several challenges that needs to be tackled in order to provide efficient ev-based lncrnas therapeutics for clinical application, but the current state of research offers promise.', '', '', '', '', '', '']\n",
      "31173220\n"
     ]
    }
   ],
   "source": [
    "for i, row in df.iterrows():\n",
    "    if row['article_id'] == 'PMC662519':\n",
    "        print(row[\"full_text\"])\n",
    "        print(row[\"sections\"])\n",
    "        print(row[\"pmid\"])\n",
    "        break"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "gptoss20b",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.18"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
